BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871. [PMID: 10733541 DOI: 10.1053/he.2000.5852] [Cited by in Crossref: 1747] [Cited by in F6Publishing: 1539] [Article Influence: 79.4] [Reference Citation Analysis]
Number Citing Articles
1 Saeed D, Potapov E, Loforte A, Morshuis M, Schibilsky D, Zimpfer D, Riebandt J, Pappalardo F, Attisani M, Rinaldi M, Haneya A, Ramjankhan F, Donker DW, Jorde UP, Stein J, Tsyganenko D, Jawad K, Wieloch R, Ayala R, Cremer J, Borger MA, Lichtenberg A, Gummert J; Durable MCS after ECLS Study Group. Transition From Temporary to Durable Circulatory Support Systems. J Am Coll Cardiol 2020;76:2956-64. [PMID: 33334424 DOI: 10.1016/j.jacc.2020.10.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
2 Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005;22:1079-89. [PMID: 16305721 DOI: 10.1111/j.1365-2036.2005.02691.x] [Cited by in Crossref: 221] [Cited by in F6Publishing: 213] [Article Influence: 13.8] [Reference Citation Analysis]
3 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
4 Zhang YX, Zhang XH, Yu XL, Han ZY, Yu J, Liu FY, Cheng ZG, Liang P. Prognosis of microwave ablation for hepatocellular carcinoma: does age make a difference? Int J Hyperthermia 2020;37:688-95. [PMID: 32558602 DOI: 10.1080/02656736.2020.1778198] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zielsdorf SM, Kubasiak JC, Janssen I, Myers JA, Luu MB. A NSQIP Analysis of MELD and Perioperative Outcomes in General Surgery. The American Surgeon 2015;81:755-9. [DOI: 10.1177/000313481508100811] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
6 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa080120910.1053/jhep.2001.22172] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Efird LM, Mishkin DS, Berlowitz DR, Ash AS, Hylek EM, Ozonoff A, Reisman JI, Zhao S, Jasuja GK, Rose AJ. Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease. Circ Cardiovasc Qual Outcomes 2014;7:461-7. [DOI: 10.1161/circoutcomes.113.000817] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
8 Hassoun Z, Pomier-Layrargues G. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Eur J Gastroenterol Hepatol. 2004;16:1-4. [PMID: 15095845 DOI: 10.1097/00042737-200401000-00001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
9 Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2009;104:2458-2466. [PMID: 19532126 DOI: 10.1038/ajg.2009.321] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis]
10 Hillebrand DJ. Spontaneous Bacterial Peritonitis. Curr Treat Options Gastroenterol. 2002;5:479-489. [PMID: 12408785 DOI: 10.1007/s11938-002-0036-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis. Liver Int. 2010;30:1033-1042. [PMID: 20492502 DOI: 10.1111/j.1478-3231.2010.02255.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
12 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Hackl C, Schlitt HJ, Melter M, Knoppke B, Loss M. Current developments in pediatric liver transplantation. World J Hepatol 2015; 7(11): 1509-1520 [PMID: 26085910 DOI: 10.4254/wjh.v7.i11.1509] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
14 Degre D, Bourgeois N, Boon N, Moine O, Louis H, Donckier V, Nakadi I, Closset J, Lingier P, Vereerstraeten P, Gelin M, Adler M. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transplant Int 2004;17:31-8. [DOI: 10.1111/j.1432-2277.2004.tb00380.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Tian X, Shi Y, Hu J, Wang G, Zhang C. Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding. Hepatol Int 2013;7:636-44. [DOI: 10.1007/s12072-013-9433-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-1026. [PMID: 18768945 DOI: 10.1056/nejmoa0801209] [Cited by in Crossref: 752] [Cited by in F6Publishing: 270] [Article Influence: 53.7] [Reference Citation Analysis]
17 Kadry Z, Schaefer EW, Shah RA, Krok K, Du P, Bezinover D, Janicki P, Jain A, Gusani NJ, Schreibman IR, Hollenbeak CS, Riley TR. Portal Hypertension: An Underestimated Entity? Annals of Surgery 2016;263:986-91. [DOI: 10.1097/sla.0000000000001299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
18 Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57:274-280. [PMID: 22521353 DOI: 10.1016/j.jhep.2012.03.018] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
19 Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol. 2002;97:2855-2860. [PMID: 12425560 DOI: 10.1111/j.1572-0241.2002.07053.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
20 Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing Concepts of Cirrhotic Coagulopathy. Am J Gastroenterol. 2017;112:274-281. [PMID: 27801884 DOI: 10.1038/ajg.2016.498] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 15.0] [Reference Citation Analysis]
21 Copelan A, Chehab M, Dixit P, Cappell MS. Safety and efficacy of angiographic occlusion of duodenal varices as an alternative to TIPS: review of 32 cases. Ann Hepatol. 2015;14:369-379. [PMID: 25864218 DOI: 10.1016/s1665-2681(19)31277-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas H, Thacker LR, O'Leary JG; North American Consortium for the Study of End-Stage Liver Disease. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200-208. [PMID: 26690389 DOI: 10.1002/hep.28414] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 22.0] [Reference Citation Analysis]
23 Kakisaka K, Suzuki Y, Abe H, Watanabe T, Yusa K, Sato H, Takikawa Y. Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury. Sci Rep 2020;10:17280. [PMID: 33057105 DOI: 10.1038/s41598-020-74466-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant. 2007;7:685-692. [PMID: 17217437 DOI: 10.1111/j.1600-6143.2007.01666.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
25 Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150:835-853. [PMID: 26795574 DOI: 10.1053/j.gastro.2015.12.041] [Cited by in Crossref: 781] [Cited by in F6Publishing: 771] [Article Influence: 130.2] [Reference Citation Analysis]
26 Srivastava M, Rungta S, Dixit VK, Shukla SK, Singh TB, Jain AK. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective. Antiviral Res. 2013;100:300-305. [PMID: 24012998 DOI: 10.1016/j.antiviral.2013.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
27 Bleszynski MS, Bressan AK, Joos E, Morad Hameed S, Ball CG. Acute care and emergency general surgery in patients with chronic liver disease: how can we optimize perioperative care? A review of the literature. World J Emerg Surg 2018;13:32. [PMID: 30034510 DOI: 10.1186/s13017-018-0194-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 He Q, Liu P, Li X, Su K, Peng D, Zhang Z, Xu W, Qin Z, Chen S, Li Y, Qiu J. Risk factors of bloodstream infections in recipients after liver transplantation: a meta-analysis. Infection 2019;47:77-85. [DOI: 10.1007/s15010-018-1230-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Jakab F. Sebészi kockázat májbetegeken. MaSeb 2013;66:127-37. [DOI: 10.1556/maseb.66.2013.3.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Schlegel V, Treuner-Kaueroff T, Seehofer D, Berg T, Becker S, Ceglarek U, Thiery J, Kaiser T. Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease. PLoS One 2017;12:e0181540. [PMID: 28727814 DOI: 10.1371/journal.pone.0181540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
31 Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T; North American Study for the Treatment of Refractory Ascites Group. The North American Study for the Treatment of Refractory Ascites. Gastroenterology. 2003;124:634-641. [PMID: 12612902 DOI: 10.1053/gast.2003.50088] [Cited by in Crossref: 307] [Cited by in F6Publishing: 224] [Article Influence: 16.2] [Reference Citation Analysis]
32 Graziadei I, Zoller H, Fickert P, Schneeberger S, Finkenstedt A, Peck-Radosavljevic M, Müller H, Kohl C, Sperner-Unterweger B, Eschertzhuber S, Hofer H, Öfner D, Tilg H, Vogel W, Trauner M, Berlakovich G. Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX). Wien Klin Wochenschr 2016;128:679-90. [PMID: 27590261 DOI: 10.1007/s00508-016-1046-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
33 Said A, Lucey MR. Liver transplantation: an update. Curr Opin Gastroenterol. 2006;22:272-278. [PMID: 16550042 DOI: 10.1097/01.mog.0000218964.70935.3c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
34 Cai C, Chen H, Lu M, Chen G. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B: . Chinese Medical Journal 2008;121:2065-9. [DOI: 10.1097/00029330-200810020-00023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl 2010;16:1147-57. [PMID: 20879013 DOI: 10.1002/lt.22121] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
36 Ripamonti R, Ferral H, Alonzo M, Patel NH. Transjugular intrahepatic portosystemic shunt-related complications and practical solutions. Semin Intervent Radiol. 2006;23:165-176. [PMID: 21326760 DOI: 10.1055/s-2006-941447] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
37 Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7:350-391. [PMID: 19406039 DOI: 10.6004/jnccn.2009.0027] [Cited by in Crossref: 299] [Cited by in F6Publishing: 324] [Article Influence: 23.0] [Reference Citation Analysis]
38 Biggins SW, Feng S. In a MELD-based economy, how can we fight off inflation? Liver Transpl 2007;13:2-4. [DOI: 10.1002/lt.21008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
39 Allegretti AS, Solà E, Ginès P. Clinical Application of Kidney Biomarkers in Cirrhosis. American Journal of Kidney Diseases 2020;76:710-9. [DOI: 10.1053/j.ajkd.2020.03.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
40 Fukazawa K, Nishida S, Pretto EA, Vater Y, Reyes JD. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation: Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. J Hepatobiliary Pancreat Sci 2016;23:406-13. [DOI: 10.1002/jhbp.355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Leithead JA, MacKenzie SM, Ferguson JW, Hayes PC. Is estimated glomerular filtration rate superior to serum creatinine in predicting mortality on the waiting list for liver transplantation? Transpl Int 2011;24:482-8. [PMID: 21362061 DOI: 10.1111/j.1432-2277.2011.01231.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
42 Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR, D’Angelica MI, Blumgart LH, DeMatteo RP. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg. 2008;206:281-291. [PMID: 18222381 DOI: 10.1016/j.jamcollsurg.2007.07.031] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 5.5] [Reference Citation Analysis]
43 Sundsted KK, Mohabbat AB, Regan DW, Salonen BR, Daniels PR, Mauck KF. Update in perioperative medicine: practice-changing evidence published in 2015. Hosp Pract (1995) 2016;44:157-63. [PMID: 27400757 DOI: 10.1080/21548331.2016.1210473] [Reference Citation Analysis]
44 Trieb M, Rainer F, Stadlbauer V, Douschan P, Horvath A, Binder L, Trakaki A, Knuplez E, Scharnagl H, Stojakovic T, Heinemann Á, Mandorfer M, Paternostro R, Reiberger T, Pitarch C, Amorós A, Gerbes A, Caraceni P, Alessandria C, Moreau R, Clària J, Marsche G, Stauber RE. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol 2020;73:113-20. [PMID: 32061870 DOI: 10.1016/j.jhep.2020.01.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
45 Sargent JE, Dardas TF, Smith JW, Pal JD, Cheng RK, Masri SC, Shively KR, Colyer LM, Mahr C, Mokadam NA. Periportal fibrosis without cirrhosis does not affect outcomes after continuous flow ventricular assist device implantation. The Journal of Thoracic and Cardiovascular Surgery 2016;151:230-5. [DOI: 10.1016/j.jtcvs.2015.08.073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Sedrak H, Khalifa R, Elkafrawy A, Elewa H. Noninvasive predictors of large esophageal varices: is there an emerging role of aspartate aminotransferase-to-platelet ratio index in hepatocellular carcinoma? Egypt J Intern Med 2015;27:139-46. [DOI: 10.4103/1110-7782.174935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 McAvoy NC, Semple S, Richards JM, Robson AJ, Patel D, Jardine AG, Leyland K, Cooper AS, Newby DE, Hayes PC. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther. 2016;43:947-954. [PMID: 26947424 DOI: 10.1111/apt.13571] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
48 Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, Sawant P. Predictors of 1-month and 3-months Hospital Readmissions in Decompensated Cirrhosis: A Prospective Study in a Large Asian Cohort. Ann Hepatol 2019;18:30-9. [PMID: 31113606 DOI: 10.5604/01.3001.0012.7859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Bie CQ, Yang DH, Tang SH, Huang W. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res. 2009;39:779-785. [PMID: 19473429 DOI: 10.1111/j.1872-034x.2009.00514.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Mathis KL, Dozois EJ, Larson DW, Cima RR, Sarmiento JM, Wolff BG, Heimbach JK, Pemberton JH. Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg. 2008;95:882-886. [PMID: 18496886 DOI: 10.1002/bjs.6210] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
51 Zheng MH, Shi KQ, Lin XF, Xiao DD, Chen LL, Liu WY, Fan YC, Chen YP. A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network. J Viral Hepat 2013;20:248-55. [PMID: 23490369 DOI: 10.1111/j.1365-2893.2012.01647.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
52 Robertson M, Ng J, Abu Shawish W, Swaine A, Skardoon G, Huynh A, Deshpande S, Low ZY, Sievert W, Angus P. Risk stratification in acute variceal bleeding: Comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding. Dig Endosc. 2019;. [PMID: 31863515 DOI: 10.1111/den.13577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
53 Harrod-Kim P, Waldman DL. Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2005;16:1459-1464. [PMID: 16319151 DOI: 10.1097/01.rvi.0000175328.72653.ca] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Huang H, Chen H, Hsu Y. Comparing the Prognosis of Patient with Alcohol and Nonalcohol-Associated Cirrhosis with Bacteremia. Alcohol and Alcoholism 2020;55:512-7. [DOI: 10.1093/alcalc/agaa057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Shalimar D, Vadiraja PK, Nayak B, Thakur B, Das P, Datta Gupta S, Panda SK, Acharya SK. Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856-864. [PMID: 26519215 DOI: 10.1111/jgh.13213] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
56 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
57 Burns CJ, Chung KK, Aden JK, Lundy JB, Nitzschke SL, Renz EM, Cancio LC. High Risk But Not Always Lethal: The Effect of Cirrhosis on Thermally Injured Adults. Journal of Burn Care & Research 2013;34:115-9. [DOI: 10.1097/bcr.0b013e318269be4a] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
58 Burgos AC, Thornburg B. Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites: Review and Update of the Literature. Semin Intervent Radiol 2018;35:165-8. [PMID: 30087519 DOI: 10.1055/s-0038-1661347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Maassel NL, Fleming MM, Luo J, Zhang Y, Pei KY. Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites. J Surg Res 2020;250:45-52. [PMID: 32018142 DOI: 10.1016/j.jss.2019.12.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Alghamdi T, Abdel-Fattah M, Zautner A, Lorf T. Preoperative model for end-stage liver disease score as a predictor for posthemihepatectomy complications. Eur J Gastroenterol Hepatol 2014;26:668-75. [PMID: 24743499 DOI: 10.1097/MEG.0000000000000035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
61 Du SD, Che L, Mao YL. Liver function assessment: Application and improvement in clinical practice. Shijie Huaren Xiaohua Zazhi 2012; 20(27): 2549-2553 [DOI: 10.11569/wcjd.v20.i27.2549] [Reference Citation Analysis]
62 Staufer K, Kivaranovic D, Rasoul-Rockenschaub S, Soliman T, Trauner M, Berlakovich G. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy. HPB (Oxford) 2018;20:916-24. [PMID: 29937419 DOI: 10.1016/j.hpb.2018.03.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N. Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis: Predictive factors of tolvaptan efficacy for LC. Hepatol Res 2018;48:E311-9. [DOI: 10.1111/hepr.12988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
64 Lewis RS Jr, Vollmer CM Jr. Risk scores and prognostic models in surgery: pancreas resection as a paradigm. Curr Probl Surg 2012;49:731-95. [PMID: 23131540 DOI: 10.1067/j.cpsurg.2012.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
65 Freeman RB. Liver Allocation: The U.S. Model. Transplantation of the Liver. Elsevier; 2005. pp. 63-77. [DOI: 10.1016/b978-0-7216-0118-2.50010-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
66 Freeman RB Jr. MELD/PELD: one year later. Transplant Proc 2003;35:2425-7. [PMID: 14611977 DOI: 10.1016/j.transproceed.2003.08.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
67 Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61 [PMID: 22966483 DOI: 10.4292/wjgpt.v3.i4.49] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
68 Pascher A, Nebrig M, Neuhaus P. Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:167-73. [PMID: 23533548 DOI: 10.3238/arztebl.2013.0167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
69 Freeman RB. MELD and the quality of life. Liver Transpl 2005;11:134-6. [DOI: 10.1002/lt.20322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
70 Murray LJ, Sykes J, Brierley J, Kim JJ, Wong RKS, Ringash J, Craig T, Velec M, Lindsay P, Knox JJ, Dawson LA. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT). Int J Radiat Oncol Biol Phys. 2018;101:900-909. [PMID: 29976502 DOI: 10.1016/j.ijrobp.2018.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
71 Salvalaggio PR, Neighbors K, Kelly S, Emerick KM, Iyer K, Superina RA, Whitington PF, Alonso EM. Regional Variation and Use of Exception Letters for Cadaveric Liver Allocation in Children with Chronic Liver Disease. Am J Transplant 2005;5:1868-74. [DOI: 10.1111/j.1600-6143.2005.00962.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
72 Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: a prospective cohort study. BMC Gastroenterol 2017;17:165. [PMID: 29262794 DOI: 10.1186/s12876-017-0712-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
73 Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC;  European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962-1968. [PMID: 23389867 DOI: 10.1002/hep.26306] [Cited by in Crossref: 174] [Cited by in F6Publishing: 117] [Article Influence: 19.3] [Reference Citation Analysis]
74 Delhaye M, Moine O, Degraef C, Deviere J, Galand P. Prognostic value of hepatocyte proliferative activity after transjugular intrahepatic portosystemic shunt. Am J Gastroenterology 2001;96:1866-71. [DOI: 10.1111/j.1572-0241.2001.03885.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
75 Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y, Yao C, Jia W, Liu P. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. J Proteome Res 2016;15:1126-34. [PMID: 25964117 DOI: 10.1021/acs.jproteome.5b00217] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
76 Shin DS, Ingraham CR, Dighe MK, Wang C, Vaidya S, Moshiri M, Lall C, Park JO, Bhargava P. Surgical resection of a malignant liver lesion: what the surgeon wants the radiologist to know. AJR Am J Roentgenol 2014;203:W21-33. [PMID: 24951226 DOI: 10.2214/AJR.13.11701] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
77 Zhao ZH, Fan YC, Zhao Q, Dou CY, Ji XF, Zhao J, Gao S, Li XY, Wang K. Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure. Clin Epigenetics 2015;7:115. [PMID: 26516376 DOI: 10.1186/s13148-015-0149-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
78 Wang XH, Jiang XM, Gao PX, Liu Q, Yuan JH, Chen SJ. Risk factors and prognostic analysis of acute-on-chronic liver failure of chronic hepatitis B after cessation of nucleos(t)ide analogs. Eur J Gastroenterol Hepatol 2020;32:265-75. [PMID: 31789948 DOI: 10.1097/MEG.0000000000001574] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Hajifathalian K, Humberson A, Hanouneh MA, Barnes DS, Arora Z, Zein NN, Eghtesad B, Kelly D, Hanouneh IA. Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease. World J Hepatol 2016; 8(27): 1149-1154 [PMID: 27721920 DOI: 10.4254/wjh.v8.i27.1149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Cimen S, Guler S, Ayloo S, Molinari M. Implications of Hyponatremia in Liver Transplantation. J Clin Med 2014;4:66-74. [PMID: 26237018 DOI: 10.3390/jcm4010066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Ghaferi AA, Mathur AK, Sonnenday CJ, Dimick JB. Adverse Outcomes in Patients With Chronic Liver Disease Undergoing Colorectal Surgery. Annals of Surgery 2010;252:345-50. [DOI: 10.1097/sla.0b013e3181e982d6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
82 Perumpail RB, Wong RJ, Scandling JD, Ha le D, Todo T, Bonham CA, Saab S, Younossi ZM, Ahmed A. HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States. Clin Transplant 2015;29:920-6. [PMID: 26205329 DOI: 10.1111/ctr.12598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Lee JA, Choi G, Kim JM, Kwon CHD, Joh J. Comparison Study of Outcomes of Deceased Donor Liver Transplantation before and after Korean Model for End-Stage Liver Disease (MELD) System: Single Center Experience. J Korean Soc Transplant 2018;32:7. [DOI: 10.4285/jkstn.2018.32.1.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
84 Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, Baracos VE, Sawyer MB, Pang JX, Beaumont C, Esfandiari N, Myers RP. Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis. Clin Transl Gastroenterol 2015;6:e102. [PMID: 26181291 DOI: 10.1038/ctg.2015.31] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 22.1] [Reference Citation Analysis]
85 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
86 Toshima T, Ikegami T, Kimura K, Harimoto N, Yamashita Y, Yoshizumi T, Soejima Y, Ikeda T, Shirabe K, Maehara Y. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation. Transplant Proc. 2014;46:81-86. [PMID: 24507030 DOI: 10.1016/j.transproceed.2013.09.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
87 Basile-Filho A, Nicolini EA, Auxiliadora-Martins M, Alkmim-Teixeira GC, Martinez EZ, Martins-Filho OA, de Castro e Silva O. Comparison of acute physiology and chronic health evaluation II death risk, Child-Pugh, Charlson, and model for end-stage liver disease indexes to predict early mortality after liver transplantation. Transplant Proc. 2011;43:1660-1664. [PMID: 21693253 DOI: 10.1016/j.transproceed.2010.11.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
88 Fukazawa K, Yamada Y, Gologorsky E, Arheart KL, Pretto EA. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. J Cardiothorac Vasc Anesth. 2014;28:994-1002. [PMID: 25107717 DOI: 10.1053/j.jvca.2014.02.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
89 Hidaka M, Eguchi S. Budd-Chiari syndrome: Focus on surgical treatment. Hepatol Res 2017;47:142-8. [PMID: 27249222 DOI: 10.1111/hepr.12752] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
90 Dienstag JL, Ghany MG, Morgan TR, Di Bisceglie AM, Bonkovsky HL, Kim HY, Seeff LB, Szabo G, Wright EC, Sterling RK, Everson GT, Lindsay KL, Lee WM, Lok AS, Morishima C, Stoddard AM, Everhart JE; HALT-C Trial Group. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology 2011;54:396-405. [PMID: 21520194 DOI: 10.1002/hep.24370] [Cited by in Crossref: 111] [Cited by in F6Publishing: 109] [Article Influence: 10.1] [Reference Citation Analysis]
91 Fukuhara T, Ikegami T, Morita K, Umeda K, Ueda S, Nagata S, Sugimachi K, Gion T, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y. Impact of preoperative serum sodium concentration in living donor liver transplantation: Impact of preoperative sodium in LDLT. Journal of Gastroenterology and Hepatology 2010;25:978-84. [DOI: 10.1111/j.1440-1746.2009.06162.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
92 Sansoé G, Silvano S, Mengozzi G, Todros L, Smedile A, Touscoz G, Rosina F, Rizzetto M. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. J Hepatol 2004;40:417-23. [PMID: 15123355 DOI: 10.1016/j.jhep.2003.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
93 Schouten J, Francque S, Van Vlierberghe H, Colle I, Nevens F, Delwaide J, Adler M, Starkel P, Ysebaert D, Gadisseur A, De Winter B, Smits J, Rahmel A, Michielsen P. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth: Laboratory-induced differences in MELD score. Clinical Transplantation 2012;26:E62-70. [DOI: 10.1111/j.1399-0012.2011.01538.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
94 Northup PG, Friedman LS, Kamath PS. AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review. Clin Gastroenterol Hepatol. 2019;17:595-606. [PMID: 30273751 DOI: 10.1016/j.cgh.2018.09.043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
95 Levesque E, Hoti E, Azoulay D, Ichaï P, Habouchi H, Castaing D, Samuel D, Saliba F. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012;56:95-102. [PMID: 21835136 DOI: 10.1016/j.jhep.2011.06.024] [Cited by in Crossref: 116] [Cited by in F6Publishing: 99] [Article Influence: 10.5] [Reference Citation Analysis]
96 Saleh ZM, Solano QP, Louissaint J, Jepsen P, Tapper EB. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis. United European Gastroenterol J 2021;9:672-80. [PMID: 34102040 DOI: 10.1002/ueg2.12104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Mindikoglu AL, Raufman JP, Seliger SL, Howell CD, Magder LS. Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc 2011;43:2669-77. [PMID: 21911144 DOI: 10.1016/j.transproceed.2011.07.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
98 Maegawa FB, Shehorn L, Aziz H, Kettelle J, Jie T, Riall TS. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma. JAMA Netw Open 2019;2:e187142. [PMID: 30657533 DOI: 10.1001/jamanetworkopen.2018.7142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
99 Santori G, Andorno E, Antonucci A, Morelli N, Bottino G, Mondello R, Valente R, Panaro F, Ravazzoni F, Di Domenico S. Potential predictive value of the MELD score for short-term mortality after liver transplantation. Transplant Proc. 2004;36:533-534. [PMID: 15110583 DOI: 10.1016/j.transproceed.2004.03.079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
100 Garcia N, Sanyal AJ. Ascites. Curr Treat Options Gastroenterol. 2001;4:527-537. [PMID: 11696279 DOI: 10.1007/s11938-001-0018-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
101 Donadon M, Fontana A, Procopio F, Del Fabbro D, Cimino M, Viganò L, Palmisano A, Torzilli G. Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy? Updates Surg 2019;71:57-66. [DOI: 10.1007/s13304-019-00626-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Foxton MR, Kendrick S, Sizer E, Muiesan P, Rela M, Wendon J, Heaton ND, O'grady JG, Heneghan MA. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation. Transplant Int 2006;19:988-94. [DOI: 10.1111/j.1432-2277.2006.00377.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
103 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 133] [Cited by in F6Publishing: 109] [Article Influence: 13.3] [Reference Citation Analysis]
104 Ye Y, Liu Z, Zhao M. CLIF-OF >9 predicts poor outcome in patients with Amanita phalloides poisoning. Am J Emerg Med 2021;39:96-101. [PMID: 31982218 DOI: 10.1016/j.ajem.2020.01.027] [Reference Citation Analysis]
105 Field KM, Michael M. Part II: Liver function in oncology: towards safer chemotherapy use. Lancet Oncol. 2008;9:1181-1190. [PMID: 19038765 DOI: 10.1016/s1470-2045(08)70307-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
106 Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, Xirouchakis E, Guerrini GP, Burroughs AK, Tsochatzis E, Patch D. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 2019;64:1335-45. [PMID: 30560334 DOI: 10.1007/s10620-018-5412-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
107 Shoreibah MG, Mahmoud K, Aboueldahab NA, Vande Lune P, Massoud M, Bae S, El Khudari H, Gunn AJ, Abdel Aal AK. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol. 2019;30:154-161. [PMID: 30717946 DOI: 10.1016/j.jvir.2018.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
108 Takamoto T, Sugawara Y, Hashimoto T, Makuuchi M. Evaluating the current surgical strategies for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2016;10:341-57. [PMID: 26558422 DOI: 10.1586/17474124.2016.1116381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
109 Molinari M, Renfrew PD, Petrie NM, De Coutere S, Abdolell M. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas. Transpl Int 2011;24:292-9. [PMID: 21143650 DOI: 10.1111/j.1432-2277.2010.01200.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
110 Rosado B, Kamath PS. Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl. 2003;9:207-217. [PMID: 12619016 DOI: 10.1053/jlts.2003.50045] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
111 Batista TP, Sabat BD, Melo PS, Miranda LE, Fonseca-Neto OC, Amorim AG, Lacerda CM. Employment of MELD score for the prediction of survival after liver transplantation. Rev Col Bras Cir 2012;39:105-11. [PMID: 22664516 [PMID: 22664516 DOI: 10.1590/s0100-69912012000200005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
112 Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Vasilieva L, Archimandritis AJ. Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol 2006; 12(25): 4020-4025 [PMID: 16810751 DOI: 10.3748/wjg.v12.i25.4020] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
113 Hu N, Xie XC, Liu LL, Lai WD. Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Medicine (Baltimore) 2021;100:e26066. [PMID: 34032735 DOI: 10.1097/MD.0000000000026066] [Reference Citation Analysis]
114 Ikegami T, Yoshizumi T, Sakata K, Uchiyama H, Harimoto N, Harada N, Itoh S, Nagatsu A, Soejima Y, Maehara Y. Left lobe living donor liver transplantation in adults: What is the safety limit? Liver Transpl. 2016;22:1666-1675. [PMID: 27540888 DOI: 10.1002/lt.24611] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
115 Brown DB, Fundakowski CE, Lisker-Melman M, Crippin JS, Pilgram TK, Chapman W, Darcy MD. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2004;15:1209-1218. [PMID: 15525739 DOI: 10.1097/01.rvi.0000128123.04554.c1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
116 Riggio O, Mannaioni G, Ridola L, Angeloni S, Merli M, Carlà V, Salvatori FM, Moroni F. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy. Am J Gastroenterol. 2010;105:1374-1381. [PMID: 20125128 DOI: 10.1038/ajg.2009.738] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
117 Im GY, Lubezky N, Facciuto ME, Schiano TD. Surgery in Patients with Portal Hypertension. Clinics in Liver Disease 2014;18:477-505. [DOI: 10.1016/j.cld.2014.01.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
118 Myers RP, Shaheen AA, Aspinall AI, Quinn RR, Burak KW. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. J Hepatol. 2011;54:462-470. [PMID: 21109324 DOI: 10.1016/j.jhep.2010.07.015] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
119 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Byrne RD, Weingarten AJ, Clark DE, Huang S, Perri RE, Scanga AE, Menachem JN, Markham LW, Frischhertz BP. More than the heart: Hepatic, renal, and cardiac dysfunction in adult Fontan patients. Congenit Heart Dis 2019;14:765-71. [PMID: 31282062 DOI: 10.1111/chd.12820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
121 Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P. Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study. Am J Gastroenterol 2009;104:1147-58. [DOI: 10.1038/ajg.2009.31] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 8.8] [Reference Citation Analysis]
122 Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res. 2005;3:87-92. [PMID: 16012126 DOI: 10.3121/cmr.3.2.87] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
123 Pardo F, Pons JA, Castells L, Colmenero J, Gómez MÁ, Lladó L, Pérez B, Prieto M, Briceño J. VI consensus document by the Spanish Liver Transplantation Society. Gastroenterol Hepatol 2018;41:406-21. [PMID: 29866511 DOI: 10.1016/j.gastrohep.2018.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
124 Hasanin AS, Mahmoud FM, Soliman HM. Factors affecting acid base status during hepatectomy in cirrhotic patients. Egyptian Journal of Anaesthesia 2019;29:305-10. [DOI: 10.1016/j.egja.2013.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Boyer TD, Haskal ZJ;  American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386-400. [PMID: 15660434 DOI: 10.1002/hep.20559] [Cited by in Crossref: 286] [Cited by in F6Publishing: 226] [Article Influence: 16.8] [Reference Citation Analysis]
126 Yip TC, Chan HL, Tse Y, Lam KL, Lui GC, Wong VW, Wong GL. On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis. American Journal of Gastroenterology 2018;113:1629-38. [DOI: 10.1038/s41395-018-0247-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
127 Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Yamashita Y, Harimoto N, Toshima T, Uchiyama H, Soejima Y, Maehara Y. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation. Surg Today 2014;44:233-40. [DOI: 10.1007/s00595-013-0523-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
128 Yeh H, Smoot E, Schoenfeld DA, Markmann JF. Geographic inequity in access to livers for transplantation. Transplantation 2011;91:479-86. [PMID: 21200366 DOI: 10.1097/TP.0b013e3182066275] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
129 Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol. 2002;13:155-161. [PMID: 11830621 DOI: 10.1016/s1051-0443(07)61932-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
130 Takamoto T, Makuuchi M. Precision surgery for primary liver cancer. Cancer Biol Med 2019;16:475-85. [PMID: 31565478 DOI: 10.20892/j.issn.2095-3941.2019.0194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, Keough A, Llop E, González A, Seijo S. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412-419.e3. [PMID: 24148622 DOI: 10.1053/j.gastro.2013.10.018] [Cited by in Crossref: 157] [Cited by in F6Publishing: 115] [Article Influence: 17.4] [Reference Citation Analysis]
132 Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Oncology 2020;98:836-46. [PMID: 33027788 DOI: 10.1159/000502482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Batista TP, Sabat BD, Melo PS, Miranda LE, Fonseca-Neto OC, Amorim AG, Lacerda CM. Impact of MELD allocation policy on survival outcomes after liver transplantation: a single-center study in northeast Brazil. Clinics (Sao Paulo) 2011;66:57-64. [PMID: 21437437 DOI: 10.1590/s1807-59322011000100011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
134 Meng Z, Fang W, Meng M, Zhang J, Wang Q, Qie G, Chen M, Wang C. Risk Factors for Maternal and Fetal Mortality in Acute Fatty Liver of Pregnancy and New Predictive Models. Front Med (Lausanne) 2021;8:719906. [PMID: 34422871 DOI: 10.3389/fmed.2021.719906] [Reference Citation Analysis]
135 ter Borg PCJ, Hollemans M, van Buuren HR, Vleggaar FP, Groeneweg M, Hop WCJ, Laméris JS. Transjugular Intrahepatic Portosystemic Shunts: Long-term Patency and Clinical Results in a Patient Cohort Observed for 3–9 Years. Radiology 2004;231:537-45. [DOI: 10.1148/radiol.2312021797] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
136 Rajanayagam J, Frank E, Shepherd RW, Lewindon PJ. Artificial neural network is highly predictive of outcome in paediatric acute liver failure. Pediatr Transplantation 2013;17:535-42. [DOI: 10.1111/petr.12100] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
137 Zimmerman MA, Ghobrial RM. When shouldn't we retransplant? Liver Transpl 2005;:S14-20. [PMID: 16237729 DOI: 10.1002/lt.20599] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
138 Casadaban LC, Parvinian A, Zivin SP, Lakhoo J, Minocha J, Knuttinen MG, Ray CE, Bui JT, Gaba RC. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Annals of Hepatology 2015;14:380-8. [DOI: 10.1016/s1665-2681(19)31278-5] [Cited by in Crossref: 19] [Article Influence: 2.7] [Reference Citation Analysis]
139 Li C, Wen TF, Yan LN, Li B, Yang JY, Xu MQ, Wang WT, Wei YG. Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. PLoS One 2013;8:e72235. [PMID: 23991069 DOI: 10.1371/journal.pone.0072235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
140 Brown KA, Moonka DK. Liver transplantation. Curr Opin Gastroenterol. 2001;17:299-303. [PMID: 17031172 DOI: 10.1097/00001574-200105000-00014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Pozo-Laderas JC, Rodríguez-Perálvarez M, Muñoz-Villanueva MC, Rivera-Espinar F, Durban-García I, Muñoz-Trujillo J, Robles-Arista JC, Briceño-Delgado J. Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era. Med Intensiva (Engl Ed) 2019;43:261-9. [PMID: 29735173 DOI: 10.1016/j.medin.2018.03.008] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
142 Jacquelinet C, Audry B, Pessione F, Antoine C, Loty B, Calmus Y. Règles d’attribution des greffons hépatiques. La Presse Médicale 2008;37:1782-6. [DOI: 10.1016/j.lpm.2008.01.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
143 Kogiso T, Yamamoto K, Kobayashi M, Ikarashi Y, Kodama K, Taniai M, Torii N, Hashimoto E, Tokushige K. Response to tolvaptan and its effect on prognosis in cirrhotic patients with ascites. Hepatol Res. 2016; Epub ahead of print. [PMID: 27670393 DOI: 10.1111/hepr.12822] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
144 Neuberger J. HOPE OR EFFICACY IN DONOR LIVER ALLOCATION?: . Transplantation 2001;72:1173-6. [DOI: 10.1097/00007890-200109270-00038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
145 Asrani SK, Kim WR. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol 2010;26:209-13. [PMID: 20224394 DOI: 10.1097/MOG.0b013e32833867d8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
146 Steinebrunner N, Stein K, Sandig C, Bruckner T, Stremmel W, Pathil A. Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort. World J Gastroenterol 2018; 24(7): 852-861 [PMID: 29467555 DOI: 10.3748/wjg.v24.i7.852] [Reference Citation Analysis]
147 Malik SM, Ahmad J. Preoperative Risk Assessment for Patients with Liver Disease. Medical Clinics of North America 2009;93:917-29. [DOI: 10.1016/j.mcna.2009.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
148 Ahluwalia V, Betrapally NS, Hylemon PB, White MB, Gillevet PM, Unser AB, Fagan A, Daita K, Heuman DM, Zhou H, Sikaroodi M, Bajaj JS. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Sci Rep. 2016;6:26800. [PMID: 27225869 DOI: 10.1038/srep26800] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 15.0] [Reference Citation Analysis]
149 Akamatsu N, Sugawara Y, Kaneko J, Sano K, Imamura H, Kokudo N, Makuuchi M. Effects of middle hepatic vein reconstruction on right liver graft regeneration. Transplantation 2003;76:832-7. [PMID: 14501863 DOI: 10.1097/01.TP.0000085080.37235.81] [Cited by in Crossref: 73] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
150 Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E. Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative? Ann Gastroenterol 2019;32:626-32. [PMID: 31700241 DOI: 10.20524/aog.2019.0417] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
151 Colmenero J, Castro-Narro G, Navasa M. [The value of MELD in the allocation of priority for liver transplantation candidates]. Gastroenterol Hepatol 2010;33:330-6. [PMID: 19631411 DOI: 10.1016/j.gastrohep.2009.04.007] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
152 Moore K, Jamil K, Verleger K, Luo L, Kebede N, Heisen M, Corman S, Leonardi R, Bakker R, Maï C, Shamseddine N, Huang X, Allegretti AS. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Aliment Pharmacol Ther 2020;52:351-8. [DOI: 10.1111/apt.15836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
153 Liu H, Zhang H, Wan G, Sang Y, Chang Y, Wang X, Zeng H. Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure. J Viral Hepat. 2014;21:499-507. [PMID: 24750274 DOI: 10.1111/jvh.12160] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
154 Townsend JC, Heard R, Powers ER, Reuben A. Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization. Am J Cardiol. 2012;110:1062-1065. [PMID: 22728001 DOI: 10.1016/j.amjcard.2012.05.043] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
155 Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? Liver Transpl. 2010;16:964-973. [PMID: 20677287 DOI: 10.1002/lt.22093] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
156 Duan BW, Lu SC, Wang ML, Liu JN, Chi P, Lai W, Wu JS, Guo QL, Lin DD, Liu Y. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. J Surg Res. 2013;183:936-943. [PMID: 23558257 DOI: 10.1016/j.jss.2013.03.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
157 Reuben A. Child comes of age. Hepatology. 2002;35:244-245. [PMID: 11786987 DOI: 10.1053/jhep.2002.0350244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
158 Marlar RA. Determining the model for end-stage liver disease with better accuracy: neutralizing the international normalized ratio pitfalls. Hepatology 2007;46:295-6. [PMID: 17661420 DOI: 10.1002/hep.21833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
159 Papatheodoridis GV, Cholongitas E, Dimitriadou E, Touloumi G, Sevastianos V, Archimandritis AJ. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005; 11(20): 3099-3104 [PMID: 15918197 DOI: 10.3748/wjg.v11.i20.3099] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
160 Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173-92. [PMID: 32114503 DOI: 10.1136/gutjnl-2019-320221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
161 Machicao VI. Model for End-Stage Liver Disease–Sodium Score. Clinics in Liver Disease 2017;21:275-87. [DOI: 10.1016/j.cld.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
162 Mariante-neto G, Marroni CP, Junior ADMF, Marroni CA, Zanotelli ML, Cantisani G, Brandão AB. Impact of creatinine values on MELD scores in male and female candidates for liver transplantation. Annals of Hepatology 2013;12:434-9. [DOI: 10.1016/s1665-2681(19)31006-3] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ghabril M, Charlton M. Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice. Gastroenterology 2015;149:531-4. [PMID: 26226568 DOI: 10.1053/j.gastro.2015.07.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
164 Rosemurgy AS, Zervos EE, Clark WC, Thometz DP, Black TJ, Zwiebel BR, Kudryk BT, Grundy LS, Carey LC. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg 2004;239:883-9; discussion 889-91. [PMID: 15166968 DOI: 10.1097/01.sla.0000128309.36393.71] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
165 Marubashi S, Dono K, Asaoka T, Hama N, Gotoh K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, Monden M. Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation. Transplant Proc 2006;38:1407-10. [PMID: 16797318 DOI: 10.1016/j.transproceed.2006.02.091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
166 Mao W, Ye B, Lin S, Fu Y, Chen Y, Chen Y. Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. ASAIO J. 2010;56:475-478. [PMID: 20613491 DOI: 10.1097/mat.0b013e3181e6bf13] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
167 C S, S. M, Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry: MARS liver support therapy. Liver 2002;22:20-5. [DOI: 10.1034/j.1600-0676.2002.00003.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
168 Garcia-Tsao G. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites. Semin Intervent Radiol 2005;22:278-86. [PMID: 21326706 DOI: 10.1055/s-2005-925554] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
169 Fernández Fernández N, Linares Torres P, Joáo Matias D, Jorquera Plaza F, Olcoz Goñi JL. [Vitamin D deficiency in chronic liver disease, clinical-epidemiological analysis and report after vitamin d supplementation]. Gastroenterol Hepatol 2016;39:305-10. [PMID: 26596370 DOI: 10.1016/j.gastrohep.2015.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
170 Fikatas P, Lee JE, Sauer IM, Schmidt SC, Seehofer D, Puhl G, Guckelberger O. APACHE III score is superior to King’s College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure. Transplant Proc. 2013;45:2295-2301. [PMID: 23953541 DOI: 10.1016/j.transproceed.2013.02.125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
171 Khalifa A, Rockey DC. Lower Gastrointestinal Bleeding in Patients With Cirrhosis-Etiology and Outcomes. Am J Med Sci 2020;359:206-11. [PMID: 32087941 DOI: 10.1016/j.amjms.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Baccaro ME, Guevara M. [Hepatorenal syndrome]. Gastroenterol Hepatol 2007;30:548-54. [PMID: 17980134 DOI: 10.1157/13111697] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
173 Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, Khalaf HA. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2005;20:1494-1502. [PMID: 16174064 DOI: 10.1111/j.1440-1746.2005.03878.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
174 Kamath P. Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transplantation 2003;9:19-21. [DOI: 10.1053/jlts.2003.50031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
175 Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Ann Surg Oncol. 2014;21:1825-1833. [PMID: 24499831 DOI: 10.1245/s10434-014-3510-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
176 Mahmud N, Fricker Z, Panchal S, Lewis JD, Goldberg DS, Kaplan DE. External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems. Liver Transpl 2021;27:961-70. [PMID: 33788365 DOI: 10.1002/lt.26060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Suzuki H, Bartlett A, Muiesan P, Jassem W, Rela M, Heaton N. High Model for End-Stage Liver Disease Score as a Predictor of Survival During Long-Term Follow-up After Liver Transplantation. Transplantation Proceedings 2012;44:384-8. [DOI: 10.1016/j.transproceed.2011.11.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
178 Kovacs F, Gerlei Z, Gorog D, Varga M, Kobori L, Gaal I, Langer RM, Beresne BL, Sarvary E. Endogenous thrombin potential and examination of a further 31 analytes in liver transplant candidates. Transplant Proc 2014;46:2171-6. [PMID: 25131133 DOI: 10.1016/j.transproceed.2014.05.059] [Reference Citation Analysis]
179 Kartoun U. Toward an accelerated adoption of data-driven findings in medicine: Research, skepticism, and the need to speed up public visibility of data-driven findings. Med Health Care and Philos 2019;22:153-7. [DOI: 10.1007/s11019-018-9845-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
180 Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789-796. [PMID: 17326205 DOI: 10.1002/hep.21503] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 7.7] [Reference Citation Analysis]
181 Yalcin YC, Muslem R, Veen KM, Soliman OI, Manintveld OC, Darwish Murad S, Kilic A, Constantinescu AA, Brugts JJ, Alkhunaizi F, Birim O, Tedford RJ, Bogers AJJC, Hsu S, Caliskan K. Impact of preoperative liver dysfunction on outcomes in patients with left ventricular assist devices. Eur J Cardiothorac Surg 2020;57:920-8. [PMID: 31828334 DOI: 10.1093/ejcts/ezz337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
182 Melamed KH, Dai D, Cuk N, Markovic D, Follett R, Wang T, Lopez RC, Shirali AS, Yanagawa J, Busuttil R, Kaldas F, Barjaktarevic I. Preoperative Trapped Lung Is Associated With Increased Mortality After Orthotopic Liver Transplantation. Prog Transplant 2021;31:47-54. [PMID: 33280518 DOI: 10.1177/1526924820978604] [Reference Citation Analysis]
183 Nicoll A. Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol. 2012;27:1569-1575. [PMID: 22694313 DOI: 10.1111/j.1440-1746.2012.07205.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
184 Egger ME, Gottumukkala V, Wilks JA, Soliz J, Ilmer M, Vauthey JN, Conrad C. Anesthetic and operative considerations for laparoscopic liver resection. Surgery. 2017;161:1191-1202. [PMID: 27545995 DOI: 10.1016/j.surg.2016.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
185 Barber K, Madden S, Allen J, Collett D, Neuberger J, Gimson A. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation. 2011;92:469-476. [PMID: 21775931 DOI: 10.1097/tp.0b013e318225db4d] [Cited by in Crossref: 92] [Cited by in F6Publishing: 26] [Article Influence: 8.4] [Reference Citation Analysis]
186 Amesur NB, Zajko AB. Interventional radiology in liver transplantation. Liver Transpl. 2006;12:330-351. [PMID: 16498660 DOI: 10.1002/lt.20731] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
187 Kogiso T, Sagawa T, Kodama K, Taniai M, Tokushige K. Impact of continued administration of tolvaptan on cirrhotic patients with ascites. BMC Pharmacol Toxicol 2018;19:87. [PMID: 30563565 DOI: 10.1186/s40360-018-0277-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
188 Schiffman SC, Woodall CE, Kooby DA, Martin RC, Staley CA, Egnatashvili V, McMasters KM, Scoggins CR. Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol. 2010;101:105-110. [PMID: 20035538 DOI: 10.1002/jso.21461] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
189 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
190 Metselaar HJ, Lerut J, Kazemier G. The true merits of liver allocation according to MELD scores: survival after transplantation tells only one side of the story. Transpl Int. 2011;24:132-133. [PMID: 21208292 DOI: 10.1111/j.1432-2277.2010.01177.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
191 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
192 Bryce CL, Chang CC, Angus DC, Arnold RM, Farrell M, Roberts MS. The Effect of Race, Sex, and Insurance Status on Time-to-Listing Decisions for Liver Transplantation. J Transplant 2010;2010:467976. [PMID: 21234099 DOI: 10.1155/2010/467976] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
193 Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis. J Trauma 2011;71:6-11. [PMID: 21818010 DOI: 10.1097/TA.0b013e31822311c5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
194 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2001;17:281-90. [DOI: 10.1097/00001574-200105000-00012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
195 Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications. United European Gastroenterol J 2020;8:961-9. [PMID: 32588789 DOI: 10.1177/2050640620938525] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Rahbari NN, Garden OJ, Padbury R, Brooke-smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey J, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713-24. [DOI: 10.1016/j.surg.2010.10.001] [Cited by in Crossref: 1023] [Cited by in F6Publishing: 938] [Article Influence: 93.0] [Reference Citation Analysis]
197 Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int. 2009;29:1516-1520. [PMID: 19732329 DOI: 10.1111/j.1478-3231.2009.02104.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
198 Forman LM, Lucey MR. Setting limits on selection of adults for liver transplantation. Transplantation 2004;77:19-21. [PMID: 14750510 DOI: 10.1097/01.tp.0000101010.63541.32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Santos BC, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Bioelectrical impedance vector analysis in patients on the waiting list for liver transplant: Associated factors and prognostic effects. Nutrition 2021;94:111528. [PMID: 34891107 DOI: 10.1016/j.nut.2021.111528] [Reference Citation Analysis]
200 Lesmana CR, Cahyadinata L, Pakasi LS, Lesmana LA. Efficacy of Prothrombin Complex Concentrate Treatment in Patients with Liver Coagulopathy Who Underwent Various Invasive Hepatobiliary and Gastrointestinal Procedures. Case Rep Gastroenterol 2016;10:315-22. [PMID: 27482190 DOI: 10.1159/000447290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
201 Franck M, Thon C, Schütte K, Malfertheiner P, Link A. Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function. World J Hepatol 2020; 12(11): 1031-1045 [PMID: 33312427 DOI: 10.4254/wjh.v12.i11.1031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
202 Samuel D, Ichai P. Prognosis indicator in acute liver failure: Is there a place for cell death markers? J Hepatol 2010;53:593-5. [PMID: 20619915 DOI: 10.1016/j.jhep.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
203 Chan AC, Fan ST. Criteria for liver transplantation in ACLF and outcome. Hepatol Int. 2015;9:355-359. [PMID: 25788183 DOI: 10.1007/s12072-014-9585-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
204 Atkinson RJ, Hurlstone DP. Usefulness of prognostic indices in upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:233-242. [PMID: 18346681 DOI: 10.1016/j.bpg.2007.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
205 Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, Paar D, Schepke M, Sudhop T, Spengler U, Schild H, Sauerbruch T. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis: . European Journal of Gastroenterology & Hepatology 2002;14:723-31. [DOI: 10.1097/00042737-200207000-00003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
206 Wong GL, Hui AY, Wong VW, Chan FK, Sung JJ, Chan HL. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol. 2005;100:2205-2211. [PMID: 16181370 DOI: 10.1111/j.1572-0241.2005.50007.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
207 Goyal S, Jadaun S, Kedia S, Acharya SK, Varma S, Nayak B, Thakur B, Shalimar. Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure. Annals of Hepatology 2018;17:1042-51. [DOI: 10.5604/01.3001.0012.7205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
208 Suk KT, Kim CH, Park SH, Sung HT, Choi JY, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis. J Clin Gastroenterol. 2012;46:880-886. [PMID: 22810110 DOI: 10.1097/mcg.0b013e31825f2622] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
209 Potts JR, Verma S. Alcoholic hepatitis: diagnosis and management in 2012. Expert Rev Gastroenterol Hepatol. 2012;6:695-710. [PMID: 23237255 DOI: 10.1586/egh.12.57] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
210 Tanaka H, Imai H, Higashi T, Murase K, Matsuhashi N, Yoshida K. Pancreaticoduodenectomy combined with splenectomy for a patient with pancreatic cancer and pancytopenia due to liver cirrhosis: Case report. Int J Surg Case Rep 2021;81:105715. [PMID: 33689973 DOI: 10.1016/j.ijscr.2021.105715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Nielsen MJ, Lehmann J, Leeming DJ, Schierwagen R, Klein S, Jansen C, Strassburg CP, Bendtsen F, Møller S, Sauerbruch T, Karsdal MA, Krag A, Trebicka J. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS. Dig Dis Sci 2015;60:3456-64. [DOI: 10.1007/s10620-015-3783-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
212 Berry PA, Thomson SJ, Rahman TM, Ala A. Review article: towards a considered and ethical approach to organ support in critically-ill patients with cirrhosis. Aliment Pharmacol Ther. 2013;37:174-182. [PMID: 23157692 DOI: 10.1111/apt.12133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
213 Blanco R, Inza I, Merino M, Quiroga J, Larrañaga P. Feature selection in Bayesian classifiers for the prognosis of survival of cirrhotic patients treated with TIPS. Journal of Biomedical Informatics 2005;38:376-88. [DOI: 10.1016/j.jbi.2005.05.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
214 Harrod-Kim P, Saad WE, Waldman D. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol. 2006;17:1605-1610. [PMID: 17057001 DOI: 10.1097/01.rvi.0000240651.38289.4b] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
215 Navuluri R, Patel J, Kang L. Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding. Semin Intervent Radiol. 2012;29:169-177. [PMID: 23997408 DOI: 10.1055/s-0032-1326925] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
216 Li X, Dong M, Lin Q, Chen ZH, Ma XK, Xing YF, Wan XB, Wen JY, Wei L, Chen J, Wu XY. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.Asia Pac J Clin Oncol. 2013;9:86-92. [PMID: 23279888 DOI: 10.1111/ajco.12050] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
217 Takeshita A, Tsuda Y, Fukunishi S, Asai A, Fukuda A, Hayashi M, Hirose Y. Two healthy females with fulminant hepatic failure caused by herpes simplex virus infection. Pathol Int. 2014;64:48-50. [PMID: 24471971 DOI: 10.1111/pin.12128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
218 Schwartz DC, Lucey MR, Mcdermott JC, Rikkers LF. Variceal bleeding refractory to endoscopic management: Indications and use of balloon tamponade, interventional radiology, and surgical treatment. Techniques in Gastrointestinal Endoscopy 2005;7:49-58. [DOI: 10.1016/j.tgie.2004.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Edeline J, Blanc JF, Johnson P, Campillo-Gimenez B, Ross P, Ma YT, King J, Hubner RA, Sumpter K, Darby S, Evans J, Iwuji C, Swinson D, Collins P, Patel K, Muazzam I, Palmer DH, Meyer T. A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver Int. 2016;36:1821-1828. [PMID: 27214151 DOI: 10.1111/liv.13170] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
220 Shalimar, Acharya SK, Kumar R, Bharath G, Rout G, Gunjan D, Nayak B. Acute Liver Failure of Non-A-E Viral Hepatitis Etiology-Profile, Prognosis, and Predictors of Outcome. J Clin Exp Hepatol. 2020;10:453-461. [PMID: 33029054 DOI: 10.1016/j.jceh.2019.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643-1651. [PMID: 16697728 DOI: 10.1053/j.gastro.2006.02.008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 127] [Article Influence: 11.0] [Reference Citation Analysis]
222 Spreafico C, Sposito C, Vaiani M, Cascella T, Bhoori S, Morosi C, Lanocita R, Romito R, Chiesa C, Maccauro M, Marchianò A, Mazzaferro V. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. J Hepatol 2018;68:724-32. [PMID: 29331342 DOI: 10.1016/j.jhep.2017.12.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 13.3] [Reference Citation Analysis]
223 Stockhoff L, Muellner-Bucsics T, Markova AA, Schultalbers M, Keimburg SA, Tergast TL, Hinrichs JB, Simon N, Gerbel S, Manns MP, Mandorfer M, Cornberg M, Meyer BC, Wedemeyer H, Reiberger T, Maasoumy B. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS. Hepatol Commun 2021. [PMID: 34585537 DOI: 10.1002/hep4.1829] [Reference Citation Analysis]
224 Santos BC, Fonseca ALF, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Different combinations of the GLIM criteria for patients awaiting a liver transplant: Poor performance for malnutrition diagnosis but a potentially useful prognostic tool. Clin Nutr 2021;41:97-104. [PMID: 34864459 DOI: 10.1016/j.clnu.2021.11.008] [Reference Citation Analysis]
225 Tai K, Kuramitsu K, Kido M, Tanaka M, Komatsu S, Awazu M, Gon H, So S, Tsugawa D, Mukubo H, Terai S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T. Impact of Albumin-Bilirubin Score on Short- and Long-Term Survival After Living-Donor Liver Transplantation: A Retrospective Study. Transplant Proc 2020;52:910-9. [PMID: 32183990 DOI: 10.1016/j.transproceed.2020.01.020] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, Berkes JL, Cotler SJ. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol. 2013;24:411-420, 420.e1-4; quiz 421. [PMID: 23312989 DOI: 10.1016/j.jvir.2012.10.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
227 Zhang Q, Guo X, Zhao S, Pang X, Wang Y, Zhang Y, Chi B. Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients. Exp Ther Med 2016;11:1348-54. [PMID: 27073448 DOI: 10.3892/etm.2016.3037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
228 Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH, Berg CL. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006;101:1524-1528; quiz 1680. [PMID: 16863556 DOI: 10.1111/j.1572-0241.2006.00588.x] [Cited by in Crossref: 249] [Cited by in F6Publishing: 209] [Article Influence: 15.6] [Reference Citation Analysis]
229 Freeman RB. A decade of model for end-stage liver disease: lessons learned and need for re-evaluation of allocation policies. Curr Opin Organ Transplant. 2012;17:211-215. [PMID: 22516923 DOI: 10.1097/mot.0b013e3283534dde] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
230 De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, Forlino M, Farcomeni A, Riggio O. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2018;33:704-9. [PMID: 28753738 DOI: 10.1111/jgh.13907] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
231 Qiao CY, Li F, Teng Y, Zhao J, Hu N, Fan YC, Wang K. Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Clin Exp Med 2018;18:51-62. [PMID: 28676943 DOI: 10.1007/s10238-017-0466-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
232 Alagoz O, Maillart LM, Schaefer AJ, Roberts MS. The Optimal Timing of Living-Donor Liver Transplantation. Management Science 2004;50:1420-30. [DOI: 10.1287/mnsc.1040.0287] [Cited by in Crossref: 126] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
233 Tian Y, Lyu H, He Y, Xia Y, Li J, Shen F. Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC. J Gastrointest Surg 2018;22:615-23. [PMID: 29139083 DOI: 10.1007/s11605-017-3629-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
234 Lai JC, Terrault NA, Vittinghoff E, Biggins SW. Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant. 2010;10:2658-2664. [PMID: 21087414 DOI: 10.1111/j.1600-6143.2010.03326.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
235 Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885. [PMID: 12740346 DOI: 10.1136/gut.52.6.879] [Cited by in Crossref: 188] [Cited by in F6Publishing: 177] [Article Influence: 9.9] [Reference Citation Analysis]
236 Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transplant Int 2005;18:572-6. [DOI: 10.1111/j.1432-2277.2005.00090.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
237 Wang P, Huang G, Tam N, Wu C, Fu S, Hughes BP, Wu L, He X. Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation. Eur J Gastroenterol Hepatol 2016;28:1210-5. [PMID: 27362549 DOI: 10.1097/MEG.0000000000000690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
238 Segev DL. Evaluating Options for Utility-Based Kidney Allocation. American Journal of Transplantation 2009;9:1513-8. [DOI: 10.1111/j.1600-6143.2009.02667.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
239 Fayad L, Narciso-schiavon JL, Lazzarotto C, Ronsoni MF, Wildner LM, Bazzo ML, Schiavon LDL, Dantas-corrêa EB. The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. Annals of Hepatology 2015;14:83-92. [DOI: 10.1016/s1665-2681(19)30804-x] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
240 Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 2010;138:136-46. [PMID: 19766643 DOI: 10.1053/j.gastro.2009.09.007] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
241 Chiang HC, Chien YC, Lin PY, Lee HL, Chen YL. Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings. PLoS One 2018;13:e0206438. [PMID: 30458009 DOI: 10.1371/journal.pone.0206438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
242 Delis SG, Bakoyiannis A, Dervenis C, Tassopoulos N. Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 2009;13:2268-75. [PMID: 19662460 DOI: 10.1007/s11605-009-0977-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
243 El Mahdy HA, Abdelhamid IA, Amen AI, Abdelsameea E, Hassouna MM. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2019;20:2723-31. [PMID: 31554369 DOI: 10.31557/APJCP.2019.20.9.2723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
244 Körner T, Kropf J, Kosche B, Kristahl H, Jaspersen D, Gressner AM. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol. 2003;39:947-953. [PMID: 14642610 DOI: 10.1016/s0168-8278(03)00431-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
245 Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 2003;98:1167-1174. [PMID: 12809844 DOI: 10.1111/j.1572-0241.2003.07515.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 112] [Article Influence: 6.5] [Reference Citation Analysis]
246 Donadon M, Costa G, Cimino M, Procopio F, Fabbro DD, Palmisano A, Torzilli G. Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score. World J Surg. 2015;39:237-243. [PMID: 25217112 DOI: 10.1007/s00268-014-2786-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
247 Wiest I, Barreiros AP, Schlitt HJ, Ebert MP, Teufel A Prof. Dr. Dr. Evaluation und Notwendigkeit einer Anpassung des MELD Scores in der Eurotransplantregion. Z Gastroenterol 2021;59:991-4. [PMID: 34507377 DOI: 10.1055/a-1484-1544] [Reference Citation Analysis]
248 Hsu Y, Liou J, Chung C, Tseng C, Lin T, Chen C, Wu M, Wang H. Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding. The American Journal of Emergency Medicine 2010;28:884-90. [DOI: 10.1016/j.ajem.2009.04.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
249 Deroose JP, Kazemier G, Zondervan P, Ijzermans JN, Metselaar HJ, Alwayn IP. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford). 2011;13:417-425. [PMID: 21609375 DOI: 10.1111/j.1477-2574.2011.00310.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
250 Renfrew PD, Quan H, Doig CJ, Dixon E, Molinari M. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada. Can J Gastroenterol 2011;25:359-64. [PMID: 21876856 DOI: 10.1155/2011/454727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
251 Wizorek J, Kotru A, Lowell J. Liver Transplantation in Children and Segmental Transplantation. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 1766-77. [DOI: 10.1016/b978-1-4160-3256-4.50127-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Moini M, Hoseini-asl MK, Taghavi SA, Sagheb MM, Nikeghbalian S, Salahi H, Bahador A, Motazedian M, Jafari P, Malek-hosseini SA. Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation: Hyponatremia and liver list mortality. Clinical Transplantation 2011;25:638-45. [DOI: 10.1111/j.1399-0012.2010.01350.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
253 Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, O'Grady JG, Harrison PM, Heneghan MA. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology. 2011;53:926-934. [PMID: 21374663 DOI: 10.1002/hep.24141] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]
254 Lee H, Yoon S, Oh SY, Shin J, Kim J, Jung CW, Ryu HG. Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation. Sci Rep 2017;7:10884. [PMID: 28883401 DOI: 10.1038/s41598-017-07797-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
255 Weng HL, Cai X, Yuan X, Liebe R, Dooley S, Li H, Wang TL. Two sides of one coin: massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure. Front Physiol. 2015;6:178. [PMID: 26136687 DOI: 10.3389/fphys.2015.00178] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
256 Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;28:606-613. [PMID: 18433390 DOI: 10.1111/j.1478-3231.2008.01727.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
257 Talwalkar JA, Kim WR, Rosen CB, Kamath PS, Wiesner RH. Effect of Minimal Listing Criteria on Waiting List Registration for Liver Transplantation: A Process-Outcome Analysis. Mayo Clinic Proceedings 2003;78:431-5. [DOI: 10.4065/78.4.431] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
258 Chen R, Wang X, Dong J, Lin Z, Wu J, Cai Y, Shi K. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clinica Chimica Acta 2017;468:195-200. [DOI: 10.1016/j.cca.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
259 Causey MW, Nelson D, Johnson EK, Maykel J, Davis B, Rivadeneira DE, Champagne B, Steele SR. The impact of Model for End-Stage Liver Disease-Na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease. The American Journal of Surgery 2014;207:520-6. [DOI: 10.1016/j.amjsurg.2013.06.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
260 Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, Eghtesad B, Marcos A, Shakil AO. MELD and prediction of post-liver transplantation survival. Liver Transpl. 2006;12:440-447. [PMID: 16498643 DOI: 10.1002/lt.20721] [Cited by in Crossref: 147] [Cited by in F6Publishing: 130] [Article Influence: 9.2] [Reference Citation Analysis]
261 Rocha LL, Pessoa CM, Neto AS, do Prado RR, Silva E, de Almeida MD, Correa TD; POCKET Trial Investigators. Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial. Trials 2017;18:85. [PMID: 28241780 DOI: 10.1186/s13063-017-1835-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
262 Artru F, Louvet A. Admission des patients cirrhotiques en réanimation : le score de Child-Pugh est-il un outil pertinent ? Réanimation 2015;24:389-97. [DOI: 10.1007/s13546-015-1079-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
263 Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM. Liver transplant recipient selection: MELD vs. clinical judgment. Liver Transpl 2005;11:621-6. [PMID: 15915491 DOI: 10.1002/lt.20428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
264 Sheen SS, Park RW, Yoon D, Shin GT, Kim H, Park IW. The Model for End-stage Liver Disease score is potentially a useful predictor of hyperkalemia occurrence among hospitalized angiotensin receptor blocker users. J Clin Pharm Ther 2015;40:48-54. [PMID: 25328056 DOI: 10.1111/jcpt.12224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
265 Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol. 2004;99:255-260. [PMID: 15046213 DOI: 10.1111/j.1572-0241.2004.04034.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
266 Shukla A, Jain A, Kahalekar V, Bendkhale S, Gogtay N, Thatte U, Bhatia S. Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd-Chiari syndrome on warfarin. Hepatol Int 2019;13:214-21. [PMID: 30617764 DOI: 10.1007/s12072-018-9922-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
267 Dai C, Yu M, Hsieh M, Lee L, Hou N, Huang J, Chen S, Lin Z, Hsieh M, Wang L, Tsai J, Chang W, Chuang W. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation: Lamivudine for non-LC decompensated CHB. Liver International 2007;27:1364-70. [DOI: 10.1111/j.1478-3231.2007.01565.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
268 Guo YM, Li FY, Gong M, Zhang L, Wang JB, Xiao XH, Li J, Zhao YL, Wang LF, Zhang XF. Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial. Chin J Integr Med 2016;22:573-80. [PMID: 27220737 DOI: 10.1007/s11655-016-2582-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
269 Herden U, Grabhorn E, Briem-richter A, Ganschow R, Nashan B, Fischer L. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant. Clin Transplant 2014;28:1061-8. [DOI: 10.1111/ctr.12420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
270 Ronald J, Wang Q, Choi S, Suhocki P, Hall M, Smith T, Kim C. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation. Diagnostic and Interventional Imaging 2018;99:163-8. [DOI: 10.1016/j.diii.2017.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
271 Austin GL, Sasaki AW, Zaman A, Rabkin JM, Olyaei A, Ruimy R, Orloff SL, Ham J, Rosen HR. Comparative Analysis of Outcome Following Liver Transplantation in US Veterans. Am J Transplant 2004;4:788-95. [DOI: 10.1111/j.1600-6143.2004.00388.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
272 Molinari M, Ayloo S, Tsung A, Jorgensen D, Tevar A, Rahman SH, Jonassaint N. Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients During Their Evaluations. Transplantation 2019;103:e297-307. [PMID: 31283673 DOI: 10.1097/TP.0000000000002810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
273 Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003;9:737-740. [PMID: 12827562 DOI: 10.1053/jlts.2003.50122] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
274 Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane. Ann Hepatol 2021;27:100535. [PMID: 34560316 DOI: 10.1016/j.aohep.2021.100535] [Reference Citation Analysis]
275 Collins GS, Moons KGM. Reporting of artificial intelligence prediction models. Lancet. 2019;393:1577-1579. [PMID: 31007185 DOI: 10.1016/s0140-6736(19)30037-6] [Cited by in Crossref: 195] [Cited by in F6Publishing: 91] [Article Influence: 65.0] [Reference Citation Analysis]
276 Tsien C, Antonova L, Such J, Garcia-Martinez I, Wong F. Impact of Bacterial Translocation on Sarcopenia in Patients with Decompensated Cirrhosis.Nutrients. 2019;11. [PMID: 31590379 DOI: 10.3390/nu11102379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
277 Biegus J, Demissei B, Postmus D, Cotter G, Davison BA, Felker GM, Filippatos G, Gimpelewicz C, Greenberg B, Metra M, Severin T, Teerlink JR, Voors AA, Ponikowski P. Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. ESC Heart Fail 2019;6:1188-98. [PMID: 31568696 DOI: 10.1002/ehf2.12477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
278 Alqahtani SA. Update in liver transplantation. Curr Opin Gastroenterol. 2012;28:230-238. [PMID: 22450898 DOI: 10.1097/mog.0b013e3283527f16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
279 Shalimar, Sonika U, Kedia S, Mahapatra SJ, Nayak B, Yadav DP, Gunjan D, Thakur B, Kaur H, Acharya SK. Comparison of Dynamic Changes Among Various Prognostic Scores in Viral Hepatitis-Related Acute Liver Failure. Ann Hepatol 2018;17:403-12. [PMID: 29735790 DOI: 10.5604/01.3001.0011.7384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
280 Streba LAM, Vere CC, Streba CT, Ciurea ME. Focus on alcoholic liver disease: From nosography to treatment. World J Gastroenterol 2014; 20(25): 8040-8047 [PMID: 25009375 DOI: 10.3748/wjg.v20.i25.8040] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
281 Berquist WE, Andrus JP. The value of the PRISM scores in comparing pediatric liver transplant outcomes. Pediatr Transplant 2004;8:208-9. [PMID: 15176954 DOI: 10.1111/j.1399-3046.2004.00143.x] [Reference Citation Analysis]
282 Lee DH, Park YH, Choi SW, Nam KH, Choi ST, Kim D. The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study. Ann Surg Treat Res 2021;101:360-7. [PMID: 34934763 DOI: 10.4174/astr.2021.101.6.360] [Reference Citation Analysis]
283 Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model. Ann Surg 2016;263:538-45. [PMID: 25775062 DOI: 10.1097/SLA.0000000000001178] [Cited by in Crossref: 86] [Cited by in F6Publishing: 48] [Article Influence: 14.3] [Reference Citation Analysis]
284 Finkenstedt A, Dorn L, Edlinger M, Prokop W, Risch L, Griesmacher A, Graziadei I, Vogel W, Zoller H. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better? Liver Int. 2012;32:1211-1216. [PMID: 22380485 DOI: 10.1111/j.1478-3231.2012.02766.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
285 Campos-Varela I, Castells L. [Prognostic scores of cirrhosis]. Gastroenterol Hepatol 2008;31:439-46. [PMID: 18783690 DOI: 10.1157/13125591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
286 Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS. Re-weighting the model for end-stage liver disease score components. Gastroenterology. 2008;135:1575-1581. [PMID: 18835388 DOI: 10.1053/j.gastro.2008.08.004] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 8.2] [Reference Citation Analysis]
287 Orr JG, Currie CJ, Berni E, Goel A, Moriarty KJ, Sinha A, Gordon F, Dethier A, Dillon JF, Clark K, Richardson P, Middleton P, Patel V, Shawcross D, Preedy H, Aspinall RJ, Hudson M. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α. Liver Int 2016;36:1295-303. [PMID: 26950766 DOI: 10.1111/liv.13111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
288 Pan HC, Jenq CC, Tsai MH, Fan PC, Chang CH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA). Aliment Pharmacol Ther. 2014;40:1056-1065. [PMID: 25208465 DOI: 10.1111/apt.12953] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
289 Crawford DH, Stuart K. Adding serum sodium to model for end-stage liver disease: identifying those most at risk. J Gastroenterol Hepatol 2009;24:1804-6. [PMID: 20002937 DOI: 10.1111/j.1440-1746.2009.06028.x] [Reference Citation Analysis]
290 Jain V, Burford C, Alexander EC, Dhawan A, Joshi D, Davenport M, Heaton N, Hadzic N, Samyn M. Adult Liver Disease Prognostic Modelling for Long-term Outcomes in Biliary Atresia: An Observational Cohort Study. J Pediatr Gastroenterol Nutr 2021;73:93-8. [PMID: 33720092 DOI: 10.1097/MPG.0000000000003116] [Reference Citation Analysis]
291 Benavente-Chenhalls L, Mathis KL, Dozois EJ, Cima RR, Pemberton JH, Larson DW. Laparoscopic ileal pouch-anal anastomosis in patients with chronic ulcerative colitis and primary sclerosing cholangitis: a case-matched study. Dis Colon Rectum 2008;51:549-53. [PMID: 18317838 DOI: 10.1007/s10350-008-9250-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
292 Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A. Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation. Dig Dis Sci 2017;62:801-7. [PMID: 28054162 DOI: 10.1007/s10620-016-4423-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
293 Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006;35:201-19. [PMID: 16530121 DOI: 10.1016/j.gtc.2005.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
294 Chen Y, Liu Z, Mo Y, Li B, Zhou Q, Peng S, Li S, Kuang M. Prediction of Post-hepatectomy Liver Failure in Patients With Hepatocellular Carcinoma Based on Radiomics Using Gd-EOB-DTPA-Enhanced MRI: The Liver Failure Model. Front Oncol 2021;11:605296. [PMID: 33777748 DOI: 10.3389/fonc.2021.605296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Tabchouri N, Barbier L, Menahem B, Perarnau J, Muscari F, Fares N, D’alteroche L, Valette P, Dumortier J, Alves A, Lubrano J, Bureau C, Salamé E. Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients. J Gastrointest Surg 2019;23:2383-90. [DOI: 10.1007/s11605-018-4053-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
296 Finkenstedt A, Graziadei IW, Nachbaur K, Jaschke W, Mark W, Margreiter R, Vogel W. Transjugular intrahepatic portosystemic shunt in liver transplant recipients. World J Gastroenterol 2009; 15(16): 1999-2004 [PMID: 19399933 DOI: 10.3748/wjg.15.1999] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
297 Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, Suzuki H, Yamamoto S, Sato H, Terui Y, Miyata S, Adachi O, Kimura M, Saiki Y, Shimokawa H. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease. PLoS One 2019;14:e0225403. [PMID: 31743362 DOI: 10.1371/journal.pone.0225403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
298 Alonso IJ, Maestro OC, Gómez NF, Mateos RS, Quinto AM, Molero FC, Municio AM, Pulido JC, Segurola CL, Romero CJ. Mind the model for end-stage liver disease: model for end-stage liver disease score as an indicator of hemoderivate transfusion and survival in liver transplantation. Transplant Proc 2015;47:97-9. [PMID: 25645781 DOI: 10.1016/j.transproceed.2014.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
299 Rossi M, Mennini G, Lai Q, Ginanni Corradini S, Drudi FM, Pugliese F, Berloco PB. Liver transplantation(). J Ultrasound 2007;10:28-45. [PMID: 23396075 DOI: 10.1016/j.jus.2007.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
300 Morise Z. Laparoscopic liver resection for the patients with hepatocellular carcinoma and chronic liver disease. Transl Gastroenterol Hepatol 2018;3:41. [PMID: 30148226 DOI: 10.21037/tgh.2018.07.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
301 Norvell JP, Spivey JR. Hepatic hydrothorax. Clin Liver Dis. 2014;18:439-449. [PMID: 24679505 DOI: 10.1016/j.cld.2014.01.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
302 Graziadei I. Liver transplantation organ allocation between Child and MELD. Wien Med Wochenschr 2006;156:410-5. [DOI: 10.1007/s10354-006-0317-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
303 Gupta S, Rout G, Patel AH, Mahanta M, Kalra N, Sahu P, Sethia R, Agarwal A, Ranjan G, Kedia S, Acharya SK, Nayak B, Shalimar. Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection. J Viral Hepat 2018;25:771-8. [DOI: 10.1111/jvh.12870] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
304 Pereira R, Buglevski M, Perdigoto R, Marcelino P, Saliba F, Blot S, Starkopf J. Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care. PLoS One 2021;16:e0251498. [PMID: 33984016 DOI: 10.1371/journal.pone.0251498] [Reference Citation Analysis]
305 Juneja D, Gopal PB, Kapoor D, Raya R, Sathyanarayanan M. Profile and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med. 2012;27:373-378. [PMID: 21436171 DOI: 10.1177/0885066611400277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
306 Bert F, Larroque B, Dondero F, Durand F, Paugam-burtz C, Belghiti J, Moreau R, Nicolas-chanoine M. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transpl Infect Dis 2014;16:84-9. [DOI: 10.1111/tid.12169] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
307 Pagourelias ED, Sotiriou P, Papadopoulos CE, Cholongitas E, Giouleme O, Vassilikos V. Left Ventricular Myocardial Mechanics in Cirrhosis: A Speckle Tracking Echocardiographic Study. Echocardiography 2016;33:223-32. [DOI: 10.1111/echo.13010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
308 Xie YD, Feng B, Gao Y, Wei L. Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis. Hepatobiliary Pancreat Dis Int 2013;12:594-601. [PMID: 24322744 DOI: 10.1016/s1499-3872(13)60094-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
309 Lué A, Martinez E, Navarro M, Laredo V, Lorente S, Jose Araiz J, Agustin Garcia-gil F, Serrano MT. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation. Transplantation 2019;103:e211-5. [DOI: 10.1097/tp.0000000000002750] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
310 Bryce CL, Angus DC, Arnold RM, Chang CC, Farrell MH, Manzarbeitia C, Marino IR, Roberts MS. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092-2101. [PMID: 19645706 DOI: 10.1111/j.1600-6143.2009.02737.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
311 Hernando D, Wells SA, Vigen KK, Reeder SB. Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎). Magn Reson Imaging 2015;33:43-50. [PMID: 25305414 DOI: 10.1016/j.mri.2014.10.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
312 Frühauf NR, Fischer-fröhlich C, Kutschmann M, Schmidtmann I, Kirste G. Joint Impact of Donor and Recipient Parameters on the Outcome of Liver Transplantation in Germany. Transplantation 2011;92:1378-84. [DOI: 10.1097/tp.0b013e318236cd2f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
313 Sugawara Y, Makuuchi M, Kaneko J, Kokudo N. MELD score for selection of patients to receive a left liver graft1. Transplantation 2003;75:573-4. [DOI: 10.1097/01.tp.0000045710.78341.9b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
314 Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto Y, Hasegawa K, Yamashiki N, Kokudo N. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation. 2013;95:1142-1147. [PMID: 23572128 DOI: 10.1097/tp.0b013e318288ca83] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
315 Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, Kheradman R, Heuman D, Wang J, Gurry T, Williams R, Sikaroodi M, Fuchs M, Alm E, John B, Thacker LR, Riva A, Smith M, Taylor-Robinson SD, Gillevet PM. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology. 2017;66:1727-1738. [PMID: 28586116 DOI: 10.1002/hep.29306] [Cited by in Crossref: 254] [Cited by in F6Publishing: 212] [Article Influence: 50.8] [Reference Citation Analysis]
316 Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42 Suppl:S100-S107. [PMID: 15777564 DOI: 10.1016/j.jhep.2004.11.015] [Cited by in Crossref: 316] [Cited by in F6Publishing: 283] [Article Influence: 17.6] [Reference Citation Analysis]
317 Kim SH, Han YD, Lee JG, Kim do Y, Choi SB, Choi GH, Choi JS, Kim KS. MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesia. J Gastrointest Surg. 2011;15:2029-2035. [PMID: 21913042 DOI: 10.1007/s11605-011-1669-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
318 Wong M, Busuttil RW. Surgery in Patients with Portal Hypertension. Clin Liver Dis. 2019;23:755-780. [PMID: 31563221 DOI: 10.1016/j.cld.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
319 Kim T, Lee D, Lee JH, Lee YS, Oh BJ, Lim KS, Kim WY. Predictors of poor outcomes in patients with wild mushroom-induced acute liver injury. World J Gastroenterol 2017; 23(7): 1262-1267 [PMID: 28275306 DOI: 10.3748/wjg.v23.i7.1262] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
320 Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation. J Clin Gastroenterol. 2007;41:922-926. [PMID: 18090162 DOI: 10.1097/01.mcg.0000225639.45157.ee] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
321 Czaja AJ. Safety issues in the management of autoimmune hepatitis. Expert Opin Drug Saf. 2008;7:319-333. [PMID: 18462189 DOI: 10.1517/14740338.7.3.319] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
322 Jin JY, Zheng YB, Zheng J, Liu J, Mao YJ, Chen SG, Gao ZL, Zheng RQ. 2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol 2018;28:4465-74. [PMID: 29696433 DOI: 10.1007/s00330-018-5336-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
323 Hoffe SE, Finkelstein SE, Russell MS, Shridhar R. Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy. Cancer Control 2010;17:100-10. [PMID: 20404793 DOI: 10.1177/107327481001700205] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
324 Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The Survival Benefit of Liver Transplantation. Am J Transplant. 2005;5:307-313. [PMID: 15643990 DOI: 10.1111/j.1600-6143.2004.00703.x] [Cited by in Crossref: 577] [Cited by in F6Publishing: 475] [Article Influence: 33.9] [Reference Citation Analysis]
325 Zimmerman MA, Selim M, Kim J, Saeian K, Cinquegrani MP, Connolly L, Woehlck HJ, Lauer KK, Hong JC. Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience. Transplant Proc 2018;50:3544-8. [PMID: 30577234 DOI: 10.1016/j.transproceed.2018.08.013] [Reference Citation Analysis]
326 Kinny-Köster B, Bartels M, Becker S, Scholz M, Thiery J, Ceglarek U, Kaiser T. Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease. PLoS One 2016;11:e0159205. [PMID: 27410482 DOI: 10.1371/journal.pone.0159205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
327 Zhang Q, Han T, Li Y, Nie C, Liu H. Predictors of progression into acute-on-chronic liver failure from acute deterioration of pre-existing chronic liver disease. Hepatol Res. 2016;46:320-328. [PMID: 26234788 DOI: 10.1111/hepr.12567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
328 Bouzbib C, Sultanik P, Thabut D, Rudler M. Unsolved Questions in Salvage TIPSS: Practical Modalities for Placement, Alternative Therapeutics, and Long-Term Outcomes. Can J Gastroenterol Hepatol 2019;2019:7956717. [PMID: 31058111 DOI: 10.1155/2019/7956717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
329 Fabrizi F, Dixit V, Martin P, Messa P. Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies. Dig Dis Sci. 2011;56:1282-1289. [PMID: 21221799 DOI: 10.1007/s10620-010-1529-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
330 Cardoso NM, Silva T, Basile-Filho A, Mente ED, Castro-e-Silva O. A new formula as a predictive score of post-liver transplantation outcome: postoperative MELD-lactate. Transplant Proc. 2014;46:1407-1412. [PMID: 24935305 DOI: 10.1016/j.transproceed.2013.12.067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
331 D'Agostino D, Diaz S, Sanchez MC, Boldrini G. Management and prognosis of acute liver failure in children. Curr Gastroenterol Rep 2012;14:262-9. [PMID: 22528660 DOI: 10.1007/s11894-012-0260-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
332 Freeman RB. Liver allocation: the intent-to-treat approach. Transplant Int 2006;19:270-4. [DOI: 10.1111/j.1432-2277.2006.00294.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
333 Hsu KY, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg. 2009;33:2412-2419. [PMID: 19756859 DOI: 10.1007/s00268-009-0202-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
334 Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA. Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit 2019;41:732-9. [PMID: 31259884 DOI: 10.1097/FTD.0000000000000665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
335 Ghaziani TT, Kwo PY. How clinicians may use tests of hepatic function now and in the future. Transl Res 2021;233:1-4. [PMID: 33826945 DOI: 10.1016/j.trsl.2021.03.014] [Reference Citation Analysis]
336 Ingraham NE, Tignanelli CJ, Menk J, Chipman JG. Pre- and Peri-Operative Factors Associated with Chronic Critical Illness in Liver Transplant Recipients. Surg Infect (Larchmt) 2020;21:246-54. [PMID: 31618109 DOI: 10.1089/sur.2019.192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
337 Lau T, Ahmad J. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013;5:1-10. [PMID: 24696621 DOI: 10.2147/hmer.s9049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
338 Uña-Gorospe JA. Determination of the segmental hepatic clearance rate of 99mTc-mebrofenin and its application in the functional assessment of future liver remnant after liver resection. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:385-96. [PMID: 34663555 DOI: 10.1016/j.remnie.2021.09.001] [Reference Citation Analysis]
339 Hou W, Sanyal AJ. Ascites: diagnosis and management. Med Clin North Am. 2009;93:801-17, vii. [PMID: 19577115 DOI: 10.1016/j.mcna.2009.03.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
340 Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat 2012;19:594-600. [PMID: 22762144 DOI: 10.1111/j.1365-2893.2011.01577.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
341 Makhlouf NA, Mahran ZG, Sadek SH, Magdy DM, Makhlouf HA. Six-minute walk test before and after large-volume paracentesis in cirrhotic patients with refractory ascites: A pilot study. Arab J Gastroenterol 2019;20:81-5. [PMID: 31182343 DOI: 10.1016/j.ajg.2019.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
342 Goudsmit BFJ, Putter H, Tushuizen ME, Vogelaar S, Pirenne J, Alwayn IPJ, van Hoek B, Braat AE. Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region. Hepatology 2021;74:351-63. [PMID: 33301607 DOI: 10.1002/hep.31677] [Reference Citation Analysis]
343 Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg 2016;53:366-95. [PMID: 27585818 DOI: 10.1067/j.cpsurg.2016.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
344 Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol 2006;41:1005-10. [PMID: 17096070 DOI: 10.1007/s00535-006-1887-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
345 Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14:203-217. [PMID: 28053342 DOI: 10.1038/nrgastro.2016.193] [Cited by in Crossref: 146] [Cited by in F6Publishing: 145] [Article Influence: 29.2] [Reference Citation Analysis]
346 Ciocîrlan M, Mănuc M, Diculescu M, Ciocîrlan M. Is rectus abdominis thickness associated with survival among patients with liver cirrhosis? A prospective cohort study. Sao Paulo Med J 2019;137:401-6. [PMID: 31721939 DOI: 10.1590/1516-3180.2019.000406082019] [Reference Citation Analysis]
347 Bachir NM, Larson AM. Adult liver transplantation in the United States. Am J Med Sci. 2012;343:462-469. [PMID: 22683615 DOI: 10.1097/maj.0b013e3182308b66] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
348 Huo T, Hsu C, Lin H, Lee P, Lee J, Lee F, Hou M, Lee S. Selecting an optimal cutoff value for creatinine in the model for end-stage liver disease equation: Cutoff value for creatinine in MELD. Clinical Transplantation 2010;24:157-63. [DOI: 10.1111/j.1399-0012.2009.01099.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
349 Cavallazzi R, Awe OO, Vasu TS, Hirani A, Vaid U, Leiby BE, Kraft WK, Kane GC. Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis. J Crit Care. 2012;27:424.e1-424.e6. [PMID: 22227088 DOI: 10.1016/j.jcrc.2011.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
350 Annunziata TB, Paulino K, Fernandes R, Bento G, Stoduto G, Vasconcelos R, Demetrio L, Moreira LF. Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis. Transplant Proc 2016;48:2348-51. [PMID: 27742295 DOI: 10.1016/j.transproceed.2016.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
351 Emerson P, McPeake J, O'Neill A, Gilmour H, Forrest E, Puxty A, Kinsella J, Shaw M. The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. J Crit Care 2014;29:1131.e1-6. [PMID: 25175945 DOI: 10.1016/j.jcrc.2014.06.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
352 Chin KM, Allen JC, Teo JY, Kam JH, Tan EK, Koh Y, Goh KPB, Cheow PC, Raj P, Chow KHP, Chung YFA, Ooi LL, Chan CY, Lee SY. Predictors of post-hepatectomy liver failure in patients undergoing extensive liver resections for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:185-96. [PMID: 30215040 DOI: 10.14701/ahbps.2018.22.3.185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
353 Jiang M, Liu F, Xiong WJ, Zhong L, Xu W, Xu F, Liu YB. Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis. World J Gastroenterol 2010; 16(11): 1397-1401 [PMID: 20238407 DOI: 10.3748/wjg.v16.i11.1397] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
354 Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Intervent Radiol. 2014;37:691-697. [PMID: 23860938 DOI: 10.1007/s00270-013-0697-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
355 Guo Z, He X, Wu L, Ju W, Hu A, Tai Q, Wang D, Ma Y, Wang G, Zhu X. Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today. 2010;40:38-45. [PMID: 20037838 DOI: 10.1007/s00595-009-4114-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
356 Yu AS, Hu K. MANAGEMENT OF ASCITES. Clinics in Liver Disease 2001;5:541-68. [DOI: 10.1016/s1089-3261(05)70177-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
357 Ginès P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome. Lancet. 2003;362:1819-1827. [PMID: 14654322 DOI: 10.1016/s0140-6736(03)14903-3] [Cited by in Crossref: 414] [Cited by in F6Publishing: 102] [Article Influence: 23.0] [Reference Citation Analysis]
358 Singal AK, Hmoud BS, Guturu P, Kuo YF. Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis. J Clin Gastroenterol. 2013;47:727-733. [PMID: 23751845 DOI: 10.1097/mcg.0b013e318294148d] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
359 Moore JC, Thompson K, Lafleur B, Book LS, Jackson WD, O'Gorman MA, Black RE, Downey E Jr, Johnson DG, Matlak ME, Meyers RL, Scaife E, Guthery SL. Clinical variables as prognostic tools in pediatric-onset ulcerative colitis: a retrospective cohort study. Inflamm Bowel Dis 2011;17:15-21. [PMID: 20629099 DOI: 10.1002/ibd.21393] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
360 Cheng Y, Wei GQ, Cai QC, Jiang Y, Wu AP. Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation. Chin Med J (Engl) 2018;131:1314-20. [PMID: 29786044 DOI: 10.4103/0366-6999.232798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Kumari R, Sahu MK, Tripathy A, Uthansingh K, Behera M. Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepat Oncol 2018;5:HEP08. [PMID: 31293776 DOI: 10.2217/hep-2018-0002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
362 Lee WC, Chan KM, Chou HS, Wu TJ, Lee CF, Soong RS, Wu TH, Lee CS. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. Ann Surg. 2013;258:306-311. [PMID: 23108123 DOI: 10.1097/sla.0b013e3182754b8e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
363 Szyguła-jurkiewicz B, Nadziakiewicz P, Zakliczynski M, Szczurek W, Chraponski J, Zembala M, Gasior M. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant. Transplantation Proceedings 2016;48:1756-60. [DOI: 10.1016/j.transproceed.2016.01.079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
364 Xue R, Duan Z, Liu H, Chen L, Yu H, Ren M, Zhu Y, Jin C, Han T, Gao Z, Meng Q. A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure. Oncotarget. 2017;8:108970-108980. [PMID: 29312583 DOI: 10.18632/oncotarget.22447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
365 Murad SD, Kim WR, de Groen PC, Kamath PS, Malinchoc M, Valla D, Janssen HL. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl 2007;13:867-74. [DOI: 10.1002/lt.21171] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
366 Stewart CA, Kamath PS. Clinical Features and Management of Gastric Varices, Portal Hypertensive Gastropathy, and Ectopic Varices. In: Sanyal AJ, Shah VH, editors. Portal Hypertension. Totowa: Humana Press; 2005. pp. 267-82. [DOI: 10.1007/978-1-59259-885-4_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
367 Cui Y, Guan S, Ding J, He Y, Li Q, Wang S, Sun H. Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy. Metab Brain Dis 2019;34:213-21. [DOI: 10.1007/s11011-018-0333-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
368 Sánchez-perez B, Santoyo J, Fernández-aguilar J, Suárez M, Pérez J, Jiménez M, González-poveda I, González-sánchez A, Aranda J, De la Fuente A. Preoperative Factors and Models Predicting Mortality in Liver Transplantation. Transplantation Proceedings 2005;37:1499-501. [DOI: 10.1016/j.transproceed.2005.02.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
369 Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-radosavljevic M; for the Vienna TIPS Study Group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003;38:1043-50. [DOI: 10.1002/hep.1840380431] [Cited by in Crossref: 76] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
370 Jochum C, Bechmann L, Canbay A. Reply to the Letter to the Editor ‘Improving MELD for use in acute liver failure’. Journal of Hepatology 2011;54:1320-1. [DOI: 10.1016/j.jhep.2010.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
371 Veillon P, Gallois Y, Moal V, Fouchard-Hubert I, Charles I, Larcher F, Dib N, Boursier J, Oberti F, Laafi J, Guéchot J, Balan V, Calès P, Lunel-Fabiani F. Assessment of new hyaluronic acid assays and their impact on FibroMeter scores. Clin Chim Acta 2011;412:347-52. [PMID: 21075099 DOI: 10.1016/j.cca.2010.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
372 Cárdenas A, Arroyo V. Refractory ascites. Dig Dis. 2005;23:30-38. [PMID: 15920323 DOI: 10.1159/000084723] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
373 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
374 van Mierlo KMC, Lodewick TM, Dhar DK, van Woerden V, Kurstjens R, Schaap FG, van Dam RM, Vyas S, Malagó M, Dejong CHC, Olde Damink SWM. Validation of the peak bilirubin criterion for outcome after partial hepatectomy. HPB (Oxford) 2016;18:806-12. [PMID: 27506991 DOI: 10.1016/j.hpb.2016.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
375 Li W, Yu H, Qian A, Rong J, Zhang Y, Li X. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort. Eur Radiol 2017;27:1227-37. [DOI: 10.1007/s00330-016-4482-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
376 Björnsson E, Björnsson E, Aabakken L, Olafsson S, Bendtsen F. Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? Scandinavian Journal of Gastroenterology 2009;44:1037-47. [DOI: 10.1080/00365520903075170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
377 Silberhumer GR, Hetz H, Rasoul-rockenschaub S, Peck-radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival? Transplant Int 2006;19:275-81. [DOI: 10.1111/j.1432-2277.2006.00250.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
378 Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transplant 2011;25:755-65. [PMID: 21158918 DOI: 10.1111/j.1399-0012.2010.01366.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
379 Bouzbib C, Cluzel P, Sultanik P, Bernard-Chabert B, Massard J, Benosman H, Mallet M, Tripon S, Conti F, Thabut D, Rudler M. Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clin Res Hepatol Gastroenterol 2021;45:101593. [PMID: 33667917 DOI: 10.1016/j.clinre.2020.101593] [Reference Citation Analysis]
380 Hong YF, Chen ZH, Ma XK, Li X, Wu DH, Chen J, Dong M, Wei L, Wang TT, Ruan DY, Lin ZX, Wen JY, Lin Q, Jia CC, Wu XY. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumour Biol 2016;37:5265-73. [PMID: 26561464 DOI: 10.1007/s13277-015-4366-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
381 Pestana R, Baracat E, Massarollo P, Pereira L, Szutan L. Consequences of the Implementation of the Model for End-stage Liver Disease System for Liver Allocation in Brazil. Transplantation Proceedings 2013;45:2111-4. [DOI: 10.1016/j.transproceed.2012.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
382 Kamei H, Al-Basheer M, Shum J, Bloch M, Alejandro RH, McAlister V, Wall W, Quan D. Short- and long-term outcomes of third liver transplantation at single centre. Hepatol Int 2013;7:728-33. [PMID: 26201807 DOI: 10.1007/s12072-012-9364-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
383 Holland-fischer P, Nielsen MF, Vilstrup H, Tønner-nielsen D, Mengel A, Schmitz O, Grønbæk H. Insulin sensitivity and body composition in cirrhosis: changes after TIPS. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010;299:G486-93. [DOI: 10.1152/ajpgi.00375.2009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
384 Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, Nakatsuka K, Sakamoto C. Transjugular intrahepatic portosystemic shunt vs paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol. 2011;46:78-85. [PMID: 20632194 DOI: 10.1007/s00535-010-0282-9] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
385 Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. Eur J Gastroenterol Hepatol 2021;33:541-6. [PMID: 32398491 DOI: 10.1097/MEG.0000000000001760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD, Hellinger JC, Kang BC. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol. 2008;23:95-101. [PMID: 18171347 DOI: 10.1111/j.1440-1746.2006.04697.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
387 Asrani SK, Kamath PS. Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatol Int. 2015;9:346-354. [PMID: 26016462 DOI: 10.1007/s12072-015-9631-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
388 Mehrotra S, Kilambi V, Bui K, Gilroy R, Alexopoulos SP, Goldberg DS, Ladner DP, Klintmalm GB. A Concentric Neighborhood Solution to Disparity in Liver Access That Contains Current UNOS Districts. Transplantation 2018;102:255-78. [PMID: 28885499 DOI: 10.1097/TP.0000000000001934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
389 Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, McMahan CA. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231:231-236. [PMID: 14990811 DOI: 10.1148/radiol.2311030967] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 5.7] [Reference Citation Analysis]
390 Rana A, Jie T, Porubsky M, Habib S, Rilo H, Kaplan B, Gruessner A, Gruessner R. The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high-risk cohorts. Clin Transplant. 2013;27:627-632. [PMID: 23808891 DOI: 10.1111/ctr.12181] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
391 Soulaidopoulos S, Goulis I, Giannakoulas G, Panagiotidis T, Doumtsis P, Karasmani A, Oikonomou T, Tzoumari T, Karvounis H, Cholongitas Ε. Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis. Ann Gastroenterol 2017;30:225-31. [PMID: 28243044 DOI: 10.20524/aog.2016.0117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
392 Kim WR, Kamath PS. Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective? Gastroenterology 2008;134:641; author reply 641-2. [PMID: 18242236 DOI: 10.1053/j.gastro.2007.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
393 Allegretti AS, Frenk NE, Li DK, Seethapathy H, Vela Parada XF, Long J, Endres P, Pratt DS, Chung RT, Ganguli S, Irani Z, Yamada K. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One 2019;14:e0217442. [PMID: 31120995 DOI: 10.1371/journal.pone.0217442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
394 Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res 2018;195:25-47. [PMID: 29291380 DOI: 10.1016/j.trsl.2017.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
395 Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, Ramadori G, Fareed J, Thiel DHV. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014; 20(9): 2374-2382 [PMID: 24605035 DOI: 10.3748/wjg.v20.i9.2374] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
396 Boland BS, Dong MH, Bettencourt R, Barrett-Connor E, Loomba R. Association of serum bilirubin with aging and mortality. J Clin Exp Hepatol. 2014;4:1-7. [PMID: 25328328 DOI: 10.1016/j.jceh.2014.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
397 Gao L, Wang JF, Xiang M, Fan YC, Zhang ZG, Wang K. Expression of human glucocorticoid receptor in T lymphocytes in acute-on-chronic hepatitis B liver failure. Dig Dis Sci. 2011;56:2605-2612. [PMID: 21380616 DOI: 10.1007/s10620-011-1656-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
398 Fleming MM, Liu F, Zhang Y, Pei KY. Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy. World J Surg 2018;42:3390-7. [PMID: 29541825 DOI: 10.1007/s00268-018-4591-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
399 Motoyama H, Kobayashi A, Yokoyama T, Shimizu A, Furusawa N, Sakai H, Kitagawa N, Ohkubo Y, Tsukahara T, Miyagawa S. Liver failure after hepatocellular carcinoma surgery. Langenbecks Arch Surg 2014;399:1047-55. [PMID: 25335877 DOI: 10.1007/s00423-014-1252-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
400 Dumortier J, Besch C, Moga L, Coilly A, Conti F, Corpechot C, Bello AD, Faitot F, Francoz C, Hilleret MN, Houssel-Debry P, Jezequel C, Lavayssière L, Neau-Cransac M, Erard-Poinsot D, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION. Clin Res Hepatol Gastroenterol 2021;:101774. [PMID: 34332131 DOI: 10.1016/j.clinre.2021.101774] [Reference Citation Analysis]
401 Huang K, Ji F, Xie Z, Wu D, Xu X, Gao H, Ouyang X, Xiao L, Zhou M, Zhu D, Li L. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Sci Rep 2019;9:16462. [PMID: 31712684 DOI: 10.1038/s41598-019-53029-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
402 Cannon RM, Goldberg DS, Eckhoff DE, Anderson DJ, Orandi BJ, Locke JE. Early Outcomes With the Liver-kidney Safety Net. Transplantation 2021;105:1261-72. [PMID: 33741848 DOI: 10.1097/TP.0000000000003365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Jafri S, Gordon SC. Care of the Cirrhotic Patient. Infectious Disease Clinics of North America 2012;26:979-94. [DOI: 10.1016/j.idc.2012.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
404 Hsu HY, Yu MC, Lee CW, Tsai HI, Sung CM, Chen CW, Huang SW, Lin CY, Jeng WJ, Lee WC, Chen MF. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer. 2017;17:742. [PMID: 29121890 DOI: 10.1186/s12885-017-3748-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
405 Dabbous H, Sakr M, Abdelhakam S, Montasser I, Bahaa M, Said H, El-Meteini M. Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol 2016; 8(22): 942-948 [PMID: 27574548 DOI: 10.4254/wjh.v8.i22.942] [Reference Citation Analysis]
406 Wong RJ, Ahmed A. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database. Clin Transplant 2014;28:755-61. [DOI: 10.1111/ctr.12374] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
407 Baker EH, Thompson K, McKillop IH, Cochran A, Kirks R, Vrochides D, Martinie JB, Swan RZ, Iannitti DA. Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients. J Gastrointest Oncol. 2017;8:337-346. [PMID: 28480072 DOI: 10.21037/jgo.2016.09.06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
408 Hwang WJ, Jeon JP, Kang SH, Chung HS, Kim JY, Park CS. Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation. Korean J Anesthesiol 2010;59:160-6. [PMID: 20877699 DOI: 10.4097/kjae.2010.59.3.160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
409 Alagoz O, Maillart LM, Schaefer AJ, Roberts MS. Determining the Acceptance of Cadaveric Livers Using an Implicit Model of the Waiting List. Operations Research 2007;55:24-36. [DOI: 10.1287/opre.1060.0329] [Cited by in Crossref: 76] [Cited by in F6Publishing: 21] [Article Influence: 5.1] [Reference Citation Analysis]
410 Sandıkçı B, Maillart LM, Schaefer AJ, Roberts MS. Alleviating the Patient's Price of Privacy Through a Partially Observable Waiting List. Management Science 2013;59:1836-54. [DOI: 10.1287/mnsc.1120.1671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
411 Cucchetti A, Siniscalchi A, Ercolani G, Vivarelli M, Cescon M, Grazi GL, Faenza S, Pinna AD. Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma. Ann Surg 2007;245:902-8. [PMID: 17522516 DOI: 10.1097/01.sla.0000256356.23026.9f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
412 Goet JC, Harms MH, Carbone M, Hansen BE. Risk stratification and prognostic modelling in primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:95-106. [DOI: 10.1016/j.bpg.2018.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
413 Abbas N, Makker J, Abbas H, Balar B. Perioperative Care of Patients With Liver Cirrhosis: A Review. Health Serv Insights 2017;10:1178632917691270. [PMID: 28469455 DOI: 10.1177/1178632917691270] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
414 Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK. Which score system can best predict recipient outcomes after living donor liver transplantation? Transplant Proc 2012;44:393-5. [PMID: 22410025 DOI: 10.1016/j.transproceed.2012.01.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
415 Yip TC, Lee HW, Wong VW, Wong GL, Tse YK, Lui GC, Ahn SH, Chan HL. Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol 2020;35:1610-8. [PMID: 32032974 DOI: 10.1111/jgh.15007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery? World J Hepatol 2016; 8(7): 355-367 [PMID: 26981173 DOI: 10.4254/wjh.v8.i7.355] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
417 Yost GL, Coyle L, Bhat G, Tatooles AJ. Model for end-stage liver disease predicts right ventricular failure in patients with left ventricular assist devices. J Artif Organs 2016;19:21-8. [DOI: 10.1007/s10047-015-0853-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
418 Kisilevzky NH. TIPS para o controle das complicações da hipertensão portal: eficácia, fatores prognósticos associados e variações técnicas. Radiol Bras 2006;39:385-95. [DOI: 10.1590/s0100-39842006000600004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
419 Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One 2013;8:e79637. [PMID: 24244533 DOI: 10.1371/journal.pone.0079637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
420 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
421 Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-52. [PMID: 14517788 DOI: 10.1016/s0016-5085(03)01207-1] [Cited by in Crossref: 256] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
422 Wallia A, Parikh ND, O'Shea-Mahler E, Schmidt K, DeSantis AJ, Tian L, Levitsky J, Molitch ME. Glycemic control by a glucose management service and infection rates after liver transplantation. Endocr Pract. 2011;17:546-551. [PMID: 21324822 DOI: 10.4158/ep10343.or] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
423 Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014;98:119-152. [PMID: 24266918 DOI: 10.1016/j.mcna.2013.09.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
424 Carrion AF, Aye L, Martin P. Patient selection for liver transplantation. Expert Rev Gastroenterol Hepatol. 2013;7:571-579. [PMID: 23985006 DOI: 10.1586/17474124.2013.824701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
425 Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'Era A, Sei C, Mannucci PM. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology. 2007;46:520-527. [PMID: 17659574 DOI: 10.1002/hep.21732] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
426 Schlenker C, Johnson S, Trotter JF. Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries. Surg Endosc. 2009;23:1594-1598. [PMID: 19263108 DOI: 10.1007/s00464-009-0405-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
427 Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center. Transplant Proc. 2008;40:1903-1905. [PMID: 18675084 DOI: 10.1016/j.transproceed.2008.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
428 Chen YW, Chang CW, Chang CW, Wang TE, Wu CJ, Chen HH. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 2012; 4(11): 291-298 [PMID: 23293714 DOI: 10.4254/wjh.v4.i11.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
429 Yu JW, Sun LJ, Zhao YH, Li SC. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol. 2008;23:1242-1249. [PMID: 18637053 DOI: 10.1111/j.1440-1746.2008.05484.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
430 Antaki F, Lukowski A. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice. J Clin Gastroenterol 2007;41:412-5. [PMID: 17413612 DOI: 10.1097/01.mcg.0000225594.01201.9b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
431 Verna EC, Farrand ED, Elnaggar AS, Pichardo EM, Balducci A, Emond JC, Guarrera JV, Brown RS Jr. Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency. Transplantation 2011;91:1254-60. [PMID: 21617588 DOI: 10.1097/TP.0b013e318218f0f5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
432 Ohya Y, Okajima H, Honda M, Hayashida S, Suda H, Matsumoto S, Lee K, Yamamoto H, Takeichi T, Mitsubuchi H, Asonuma K, Endo F, Inomata Y. Re-evaluation of the indications for liver transplantation in Wilson's disease based on the outcomes of patients referred to a transplant center. Pediatric Transplantation 2013;17:369-73. [DOI: 10.1111/petr.12085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
433 Stotts MJ, Lisman T, Intagliata NM. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis. Semin Thromb Hemost 2020;46:716-23. [PMID: 32820482 DOI: 10.1055/s-0040-1715449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
434 Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92:551-574, viii. [PMID: 18387376 DOI: 10.1016/j.mcna.2007.12.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
435 Shi K, Fan Y, Ying L, Lin X, Song M, Li L, Yu X, Chen Y, Zheng M. Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis. Mol Biol Rep 2012;39:6161-9. [DOI: 10.1007/s11033-011-1432-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
436 Zheng ZW, Tong XC. Value of MELD score in combination with plasma endotoxin and D-dimer levels in the evaluation of the prognosis of patients with decompensated cirrhosis. Shijie Huaren Xiaohua Zazhi 2010; 18(22): 2370-2374 [DOI: 10.11569/wcjd.v18.i22.2370] [Reference Citation Analysis]
437 Moore JK, Stutchfield BM, Forbes SJ. Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther. 2014;39:673-685. [PMID: 24528093 DOI: 10.1111/apt.12645] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
438 Radisavljevic MM, Bjelakovic GB, Nagorni AV, Stojanovic MP, Radojkovicn MD, Jovic JZ, Ignjatovic AM, Radisavljevic MM, Simonovic MM. Predictors of Mortality in Long-Term Follow-Up of Patients with Terminal Alcoholic Cirrhosis: Is It Time to Accept Remodeled Scores? Med Princ Pract. 2017;26:169-175. [PMID: 27676412 DOI: 10.1159/000451057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
439 Lerrigo R, Beste LA, Leipertz SL, Green PK, Lok AS, Kogut MJ, Ioannou GN. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System. Eur J Gastroenterol Hepatol 2016;28:667-75. [PMID: 26886386 DOI: 10.1097/MEG.0000000000000604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
440 Wagner J, Garcia-Rodriguez V, Yu A, Dutra B, Bhatt A, Larson S, Farooq A. The Model for End-Stage Liver Disease-Sodium Score at Admission Is Prognostic of Covid-19 Disease Severity. SN Compr Clin Med 2020;:1-5. [PMID: 33015551 DOI: 10.1007/s42399-020-00534-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Wu J, Zhang Z, Zhu P, Mba'nbo-koumpa A, Zhang B, Chen X, Shu C, Zhang W, Feng R, Li G. Comparative liver function models for ruptured hepatocellular carcinoma: A 10-year single center experience. Asian Journal of Surgery 2019;42:874-82. [DOI: 10.1016/j.asjsur.2018.12.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
442 Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H. Living Donor Liver Transplant Versus Cadaveric Liver Transplant Survival in Relation to Model for End-Stage Liver Disease Score. Transplantation Proceedings 2015;47:1211-3. [DOI: 10.1016/j.transproceed.2015.01.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
443 Yeoman AD, Westbrook RH, Zen Y, Bernal W, Al-Chalabi T, Wendon JA, O'Grady JG, Heneghan MA. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61:876-82. [PMID: 24842305 DOI: 10.1016/j.jhep.2014.05.021] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 11.0] [Reference Citation Analysis]
444 Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, Machado P, Park S, Dianis S, Chalek CL. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013;268:581-588. [PMID: 23525208 DOI: 10.1148/radiol.13121769] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
445 Trivedi PJ, Reece J, Laing RW, Slaney E, Cooney R, Gunson BK, Kamarajah SK, Pinkney T, Thompson F, Muiesan P, Schlegel A, Hirschfield GM, Iqbal T, Ferguson J. The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis. Aliment Pharmacol Ther 2018;48:322-32. [PMID: 29882252 DOI: 10.1111/apt.14828] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
446 Campani C, Vitale A, Dragoni G, Arena U, Laffi G, Cillo U, Giannini EG, Tovoli F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Mega A, Guarino M, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Biasini E, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Brunetto MR, Farinati F, Trevisani F, Marra F. Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Liver Cancer 2021;10:126-36. [PMID: 33977089 DOI: 10.1159/000513404] [Reference Citation Analysis]
447 Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl. 2012;18:434-443. [PMID: 22271656 DOI: 10.1002/lt.23394] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 10.7] [Reference Citation Analysis]
448 Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L; American Association for the Study of Liver Diseases; United States Food and Drug Administration. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology. 2015;61:1392-1405. [PMID: 25557690 DOI: 10.1002/hep.27678] [Cited by in Crossref: 213] [Cited by in F6Publishing: 194] [Article Influence: 30.4] [Reference Citation Analysis]
449 Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005;9:1207-115; discussion 1215. [PMID: 16332475 DOI: 10.1016/j.gas20637944,] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 Wai C, Woon W, Tan Y, Lee K, Tan K. Pretransplant Model for End-stage Liver Disease Score Has No Impact on Posttransplant Survival in Living Donor Liver Transplantation. Transplantation Proceedings 2012;44:396-8. [DOI: 10.1016/j.transproceed.2012.01.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
451 Zhou L, Dong PL, Ding HG. Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China. World J Gastroenterol 2007; 13(21): 2999-3002 [PMID: 17589954 DOI: 10.3748/wjg.v13.i21.2999] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
452 Hur J, Lee KH, Lee JH, Yu JS, Won JY, Lee DY. Stent-graft for TIPS in a hepatocellular carcinoma patient with main portal vein invasion. AJR Am J Roentgenol. 2004;182:1301-1304. [PMID: 15100136 DOI: 10.2214/ajr.182.5.1821301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
453 Donadon M, Fontana A, Palmisano A, Viganò L, Procopio F, Cimino M, Del Fabbro D, Torzilli G. Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB 2017;19:910-8. [DOI: 10.1016/j.hpb.2017.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
454 Bleibel W, Caldwell SH, Curry MP, Northup PG. Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list. Transpl Int 2013;26:435-42. [DOI: 10.1111/tri.12064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
455 Grodin JL, Gallup D, Anstrom KJ, Felker GM, Chen HH, Tang WHW. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). Am J Cardiol 2017;119:2003-9. [PMID: 28433216 DOI: 10.1016/j.amjcard.2017.03.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
456 Zhang J, Li J, Chen Y, Ding M, Duan Z. Prognostic Factors Related to the Mortality Rate of Acute-on-Chronic Liver Failure Patients. Diabetes Metab Syndr Obes 2021;14:2573-80. [PMID: 34135609 DOI: 10.2147/DMSO.S309641] [Reference Citation Analysis]
457 Shao J, Liang Y, Li Y, Ding R, Zhu M, You W, Wang Z, Huang B, Wu M, Zhang T, Li K, Wu W, Wu L, Wang Q, Xia X, Wang S, Lu L. Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatol Int. 2021;15:202-212. [PMID: 33548030 DOI: 10.1007/s12072-020-10123-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
458 Suzuki K, Claggett B, Minamisawa M, Packer M, Zile MR, Rouleau J, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Zucker SD, Solomon SD. Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction. Eur J Heart Fail 2020;22:1662-71. [PMID: 32407608 DOI: 10.1002/ejhf.1853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
459 Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011;15:685-698. [PMID: 22032523 DOI: 10.1016/j.cld.2011.08.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
460 Westbrook RH, Yeoman AD, O'Grady JG, Harrison PM, Devlin J, Heneghan MA. Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol. 2011;9:694-699. [PMID: 21570482 DOI: 10.1016/j.cgh.2011.03.036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
461 Attia K, Ackoundou-N’guessan K, N’dri-yoman A, Mahassadi A, Messou E, Bathaix Y, Kissi Y. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol 2008; 14(2): 286-291 [PMID: 18186569 DOI: 10.3748/wjg.14.286] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
462 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut 2021;70:9-29. [PMID: 33067334 DOI: 10.1136/gutjnl-2020-321790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
463 Kim JM, Lee YS, Lee JH, Kim W, Lim KS. [Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A]. Korean J Hepatol 2008;14:474-82. [PMID: 19119242 DOI: 10.3350/kjhep.2008.14.4.474] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
464 Noda Y, Goshima S, Okuaki T, Akamine Y, Kajita K, Kawai N, Kawada H, Tanahashi Y, Matsuo M. Hepatocyte fraction: correlation with noninvasive liver functional biomarkers. Abdom Radiol 2020;45:83-9. [DOI: 10.1007/s00261-019-02238-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
465 Vaishnav M, Elhence A, Biswas S, Pathak P, Anand A, Sheikh S, Singh V, Maitra S, Goel A, Shalimar. The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. J Clin Exp Hepatol 2021. [PMID: 34840484 DOI: 10.1016/j.jceh.2021.11.009] [Reference Citation Analysis]
466 Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation. 2009;87:763-770. [PMID: 19295324 DOI: 10.1097/tp.0b013e318198d734] [Cited by in Crossref: 104] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
467 Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD. Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study. Metab Brain Dis 2016;31:1315-25. [PMID: 26251205 DOI: 10.1007/s11011-015-9716-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
468 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 55.7] [Reference Citation Analysis]
469 Adachi M, Tanaka A, Aiso M, Takamori Y, Takikawa H. Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis. Hepatol Res. 2015;45:1299-1306. [PMID: 25704216 DOI: 10.1111/hepr.12508] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
470 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
471 Weber ML, Ibrahim HN, Lake JR. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl. 2012;18:1290-1301. [PMID: 22847917 DOI: 10.1002/lt.23522] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.2] [Reference Citation Analysis]
472 Ecker BL, Bartlett EK, Hoffman RL, Karakousis GC, Roses RE, Morris JB, Kelz RR. Hernia repair in the presence of ascites. Journal of Surgical Research 2014;190:471-7. [DOI: 10.1016/j.jss.2014.05.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
473 Pantel HJ, Stensland KD, Nelson J, Francone TD, Roberts PL, Marcello PW, Read T, Ricciardi R. Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery? J Gastrointest Surg 2016;20:1511-6. [PMID: 27216407 DOI: 10.1007/s11605-016-3167-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
474 Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl. 2010;16:950-959. [PMID: 20589647 DOI: 10.1002/lt.22098] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
475 Clemens MM, McGill MR, Apte U. Mechanisms and biomarkers of liver regeneration after drug-induced liver injury. Adv Pharmacol. 2019;85:241-262. [PMID: 31307589 DOI: 10.1016/bs.apha.2019.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
476 Huang KC, Tsai YH, Huang KC, Lee MS. Model for end-stage liver disease (MELD) score as a predictor and monitor of mortality in patients with Vibrio vulnificus necrotizing skin and soft tissue infections. PLoS Negl Trop Dis 2015;9:e0003720. [PMID: 25923115 DOI: 10.1371/journal.pntd.0003720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
477 Vargas V, Ortiz M. Modelos pronósticos en la cirrosis hepática. El modelo MELD. Gastroenterología y Hepatología 2003;26:257-9. [DOI: 10.1016/s0210-5705(03)70350-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
478 Le Corvec M, Jezequel C, Monbet V, Fatih N, Charpentier F, Tariel H, Boussard-Plédel C, Bureau B, Loréal O, Sire O, Bardou-Jacquet E. Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis. PLoS One 2017;12:e0185997. [PMID: 29020046 DOI: 10.1371/journal.pone.0185997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
479 Wallace MJ, Madoff DC, Ahrar K, Warneke CL. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer. 2004;101:337-345. [PMID: 15241832 DOI: 10.1002/cncr.20367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
480 Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72. [PMID: 19778459 DOI: 10.1186/1471-230X-9-72] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
481 Ling JEH, Fink M, Westall G, Macdonald P, Clayton PA, Holdsworth R, Opdam H, Polkinghorne KR, Kanellis J. Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review From an Australian Perspective. Transplantation 2019;103:875-89. [PMID: 30801513 DOI: 10.1097/TP.0000000000002613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
482 Deo SV, Daly RC, Altarabsheh SE, Hasin T, Zhao Y, Shah IK, Stulak JM, Boilson BA, Schirger JA, Joyce LD, Park SJ. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation. ASAIO J 2013;59:57-62. [PMID: 23263341 DOI: 10.1097/MAT.0b013e31827c0c77] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 3.1] [Reference Citation Analysis]
483 Hosokawa I, Adam R, Allard M, Pittau G, Vibert E, Cherqui D, Sa Cunha A, Bismuth H, Miyazaki M, Castaing D. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. British Journal of Surgery 2017;104:443-51. [DOI: 10.1002/bjs.10431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
484 Castro R, Deisanti D, Seva-pereira T, Almeida J, Yamanaka A, Boin I, Soares E. Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List. Transplantation Proceedings 2010;42:412-6. [DOI: 10.1016/j.transproceed.2010.01.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
485 Darwish Murad S, Luong TK, Pattynama PM, Hansen BE, van Buuren HR, Janssen HL. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome. Liver Int. 2008;28:249-256. [PMID: 18251982 DOI: 10.1111/j.1478-3231.2007.01649.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
486 Zhou YF, Zhou YJ, Ye FZ, Liu WY, Zheng MH. A Novel Use of Model for End-Stage Liver Disease (MELD) Score in Guiding Therapeutic Antibiotics Choice for Critically Ill Cirrhotic Patients. Med Sci Monit 2019;25:5005-14. [PMID: 31278890 DOI: 10.12659/MSM.914409] [Reference Citation Analysis]
487 Hong G, Lee KW, Suh S, Yoo T, Kim H, Park MS, Choi Y, Yi NJ, Suh KS. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci. 2013;28:1207-1212. [PMID: 23960449 DOI: 10.3346/jkms.2013.28.8.1207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
488 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
489 McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492-499. [PMID: 20580460 DOI: 10.1016/j.jhep.2010.03.023] [Cited by in Crossref: 91] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
490 Shalimar, Vaishnav M, Elhence A, Kumar R, Mohta S, Palle C, Kumar P, Ranjan M, Vajpai T, Prasad S, Yegurla J, Dhooria A, Banyal V, Agarwal S, Bansal R, Bhattacharjee S, Aggarwal R, Soni KD, Rudravaram S, Singh AK, Altaf I, Choudekar A, Mahapatra SJ, Gunjan D, Kedia S, Makharia G, Trikha A, Garg P, Saraya A. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. J Clin Exp Hepatol 2021;11:327-33. [PMID: 33519132 DOI: 10.1016/j.jceh.2020.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
491 Toso C, Majno P, Berney T, Morel P, Mentha G, Combescure C. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list. Transpl Int. 2014;27:686-695. [PMID: 24649861 DOI: 10.1111/tri.12323] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
492 Jang JG, Oh SH, Kim YB, Kim SH, Yoo HW, Lee BH, Namgoong JM, Kim DY, Kim KH, Song GW, Moon DB, Hwang S, Lee SG, Kim KM. Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia. Pediatr Gastroenterol Hepatol Nutr 2021;24:288-94. [PMID: 34046332 DOI: 10.5223/pghn.2021.24.3.288] [Reference Citation Analysis]
493 Amin MG, Wolf MP, Tenbrook JA, Freeman RB, Cheng SJ, Pratt DS, Wong JB. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis. Liver Transpl 2004;10:1468-75. [DOI: 10.1002/lt.20304] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 4.8] [Reference Citation Analysis]
494 Damen JAAG, Debray TPA, Pajouheshnia R, Reitsma JB, Scholten RJPM, Moons KGM, Hooft L. Empirical evidence of the impact of study characteristics on the performance of prediction models: a meta-epidemiological study. BMJ Open 2019;9:e026160. [PMID: 30940759 DOI: 10.1136/bmjopen-2018-026160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
495 Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE Jr. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021;298:493-504. [PMID: 33497318 DOI: 10.1148/radiol.2021201960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 165.0] [Reference Citation Analysis]
497 Gastaca M, Matarranz A, Martinez L, Valdivieso A, Ruiz P, Ventoso A, Fernandez JR, Palomares I, Prieto M, Suarez MJ, Ortiz de Urbina J. Risk factors for biliary complications after orthotopic liver transplantation with T-tube: a single-center cohort of 743 transplants. Transplant Proc 2014;46:3097-9. [PMID: 25420833 DOI: 10.1016/j.transproceed.2014.09.173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
498 Russo MW, Jacques PF, Mauro M, Odell P, Brown RS. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transpl. 2002;8:271-277. [PMID: 11910573 DOI: 10.1053/jlts.2002.31653] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
499 Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, Meira-Filho SP, Rezende MB, Paes AT, Afonso RC. Analysis of liver transplantation outcome in patients with MELD Score > or = 30. Transplant Proc. 2008;40:797-799. [PMID: 18455020 DOI: 10.1016/j.transproceed.2008.03.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
500 Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS Jr. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review. J Intensive Care Med 2021;36:524-41. [PMID: 32079443 DOI: 10.1177/0885066620903027] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
501 Kaneko J, Sugawara Y, Tamura S, Aoki T, Hasegawa K, Yamashiki N, Kokudo N. Long-term outcome of living donor liver transplantation for primary biliary cirrhosis. Transpl Int 2012;25:7-12. [PMID: 21923804 DOI: 10.1111/j.1432-2277.2011.01336.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
502 Atalay R, Ersoy R, Demirezer AB, Akın FE, Polat SB, Cakir B, Ersoy O. Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver. Endocrine 2015;48:942-8. [PMID: 25063309 DOI: 10.1007/s12020-014-0364-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
503 Kogiso T, Tokushige K. Fontan-associated liver disease and hepatocellular carcinoma in adults. Sci Rep 2020;10:21742. [PMID: 33303924 DOI: 10.1038/s41598-020-78840-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
504 Yu X, Lu Y, Sun S, Tu H, Xu X, Gong K, Yao J, Shi Y, Sheng J. Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report. J Clin Transl Hepatol 2021;9:838-49. [PMID: 34966647 DOI: 10.14218/JCTH.2021.00005] [Reference Citation Analysis]
505 Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF. Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation. 2004;77:99-106. [PMID: 14724442 DOI: 10.1097/01.tp.0000101009.91516.fc] [Cited by in Crossref: 201] [Cited by in F6Publishing: 39] [Article Influence: 11.2] [Reference Citation Analysis]
506 Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant. 2006;6:1416-1421. [PMID: 16686765 DOI: 10.1111/j.1600-6143.2006.01321.x] [Cited by in Crossref: 149] [Cited by in F6Publishing: 134] [Article Influence: 9.3] [Reference Citation Analysis]
507 Habib A, Sanyal AJ. Acute Variceal Hemorrhage. Gastrointest Endosc Clin N Am. 2007;17:223-252. [PMID: 17556146 DOI: 10.1016/j.giec.2007.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
508 Goldberg DS, French B, Thomasson A, Reddy KR, Halpern SD. Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation. 2011;91:1148-1152. [PMID: 21544035 DOI: 10.1097/tp.0b013e31821694b3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
509 Andriulli A, Nardi A, Di Marco V, Ippolito AM, Gavrila C, Aghemo A, Di Paolo D, Squadrito G, Grassi E, Calvaruso V. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C. Dig Liver Dis. 2014;46:818-825. [PMID: 24953209 DOI: 10.1016/j.dld.2014.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
510 Kamei H, Al-Basheer M, Shum J, Bloch M, Wall W, Quan D. Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience. J Surg Res. 2013;185:877-882. [PMID: 23953787 DOI: 10.1016/j.jss.2013.07.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
511 Gimson AES. Transjugular intrahepatic portosystemic stent-shunt and liver transplantation – how safe is the bridge?: . European Journal of Gastroenterology & Hepatology 2002;14:821-2. [DOI: 10.1097/00042737-200208000-00001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
512 Liu HT, Cheng SB, Wu CC, Yeh HZ, Chang CS, Wang J. Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients. World J Surg. 2015;39:461-468. [PMID: 25338186 DOI: 10.1007/s00268-014-2811-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
513 Kim GY, Bae KS, Noh GJ, Min WK. Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin, and albumin. J Hepatobiliary Pancreat Surg 2009;16:521-8. [DOI: 10.1007/s00534-009-0097-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
514 Sharma P, Schaubel DE, Guidinger MK, Merion RM. Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl. 2009;15:1808-1813. [PMID: 19938142 DOI: 10.1002/lt.21951] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
515 Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 2018;67:1568-94. [PMID: 29593060 DOI: 10.1136/gutjnl-2017-315259] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 23.3] [Reference Citation Analysis]
516 Kathpalia P, Bhatia A, Robertazzi S, Ahn J, Cohen SM, Sontag S, Luke A, Durazo-arvizu R, Pillai AA. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites: Peritoneal drains for refractory ascites. Intern Med J 2015;45:1026-31. [DOI: 10.1111/imj.12843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
517 Helling G, Wahlin S, Smedberg M, Pettersson L, Tjäder I, Norberg Å, Rooyackers O, Wernerman J. Plasma Glutamine Concentrations in Liver Failure. PLoS One 2016;11:e0150440. [PMID: 26938452 DOI: 10.1371/journal.pone.0150440] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
518 Duvoux C, Samuel D. La transplantation hépatique. Gastroentérologie Clinique et Biologique 2009;33:868-81. [DOI: 10.1016/j.gcb.2009.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
519 Chan K, Yeh J, Sun W. The role of autonomic dysfunction in predicting 1-year mortality after liver transplantation. Liver Int 2017;37:1239-48. [DOI: 10.1111/liv.13364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
520 O'Leary JG, Trotter JF. Is MELD fit enough? Gastroenterology. 2011;140:1871-1874. [PMID: 21521638 DOI: 10.1053/j.gastro.2011.04.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
521 Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Guarrera JV, Brown Jr RS, Emond JC. Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation. American Journal of Transplantation 2008;8:2537-46. [DOI: 10.1111/j.1600-6143.2008.02400.x] [Cited by in Crossref: 272] [Cited by in F6Publishing: 233] [Article Influence: 19.4] [Reference Citation Analysis]
522 Shah VH, Kamath PS. Portal Hypertension and Gastrointestinal Bleeding. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1489-1516.e5. [DOI: 10.1016/b978-1-4160-6189-2.00090-1] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
523 Zaydfudim VM, Turrentine FE, Smolkin ME, Bauer TB, Adams RB, McMurry TL. The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Am J Surg 2020;220:682-6. [PMID: 31983407 DOI: 10.1016/j.amjsurg.2020.01.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
524 Yan Y, Mai L, Zheng YB, Zhang SQ, Xu WX, Gao ZL, Ke WM. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients? World J Gastroenterol 2012; 18(33): 4604-4609 [PMID: 22969236 DOI: 10.3748/wjg.v18.i33.4604] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
525 Bellavance EC, Lumpkins KM, Mentha G, Marques HP, Capussotti L, Pulitano C, Majno P, Mira P, Rubbia-brandt L, Ferrero A, Aldrighetti L, Cunningham S, Russolillo N, Philosophe B, Barroso E, Pawlik TM. Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation? J Gastrointest Surg 2008;12:1699-708. [DOI: 10.1007/s11605-008-0652-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
526 Venkat R, Hannallah JR, Krouse RS, Maegawa FB. Preoperative thrombocytopenia and outcomes of hepatectomy for hepatocellular carcinoma. Journal of Surgical Research 2016;201:498-505. [DOI: 10.1016/j.jss.2015.08.038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
527 Sandhu BS, Sanyal AJ. Management of ascites in cirrhosis. Clin Liver Dis. 2005;9:715-732, viii. [PMID: 16207572 DOI: 10.1016/j.cld.2005.07.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
528 Jurado-García J, Muñoz García-Borruel M, Rodríguez-Perálvarez ML, Ruíz-Cuesta P, Poyato-González A, Barrera-Baena P, Fraga-Rivas E, Costán-Rodero G, Briceño-Delgado J, Montero-Álvarez JL, de la Mata-García M. Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLoS One 2016;11:e0155822. [PMID: 27299728 DOI: 10.1371/journal.pone.0155822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
529 Kim JJ, Kim JH, Koo JK, Choi YJ, Ko SY, Choe WH, Kwon SY. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites. Clin Mol Hepatol 2014;20:47-55. [PMID: 24757658 DOI: 10.3350/cmh.2014.20.1.47] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
530 Croome KP, Wall W, Quan D, Vangala S, Mcalister V, Marotta P, Hernandez-alejandro R. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary & Pancreatic Diseases International 2012;11:372-6. [DOI: 10.1016/s1499-3872(12)60194-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 3.9] [Reference Citation Analysis]
531 Briceño J, Cruz-Ramírez M, Prieto M, Navasa M, Ortiz de Urbina J, Orti R, Gómez-Bravo MÁ, Otero A, Varo E, Tomé S, Clemente G, Bañares R, Bárcena R, Cuervas-Mons V, Solórzano G, Vinaixa C, Rubín A, Colmenero J, Valdivieso A, Ciria R, Hervás-Martínez C, de la Mata M. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. J Hepatol 2014;61:1020-8. [PMID: 24905493 DOI: 10.1016/j.jhep.2014.05.039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
532 Smith DL, Shire NJ, Watts NB, Schmitter T, Szabo G, Zucker SD. Hyperbilirubinemia Is Not a Major Contributing Factor to Altered Bone Mineral Density in Patients With Chronic Liver Disease. Journal of Clinical Densitometry 2006;9:105-13. [DOI: 10.1016/j.jocd.2005.10.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
533 Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology. 2014;59:1514-1521. [PMID: 24037821 DOI: 10.1002/hep.26704] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 10.1] [Reference Citation Analysis]
534 Couto BG, Goldenberg RC, da Fonseca LM, Thomas J, Gutfilen B, Resende CM, Azevedo F, Mercante DR, Torres AL, Coelho HS. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int. 2011;31:391-400. [PMID: 21281433 DOI: 10.1111/j.1478-3231.2010.02424.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
535 Wijeysundera DN. Predicting outcomes: Is there utility in risk scores? Can J Anaesth 2016;63:148-58. [PMID: 26670801 DOI: 10.1007/s12630-015-0537-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
536 Arulraj R, Neuberger J. Liver transplantation: filling the gap between supply and demand. Clin Med (Lond) 2011;11:194-8. [PMID: 21526710 DOI: 10.7861/clinmedicine.11-2-194] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
537 Roth JA, Widmer AF, Tschudin-Sutter S, Dangel M, Frei R, Battegay M, Hug BL. The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study. PLoS One 2017;12:e0175669. [PMID: 28414786 DOI: 10.1371/journal.pone.0175669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
538 Zhang QB, Chen YT, Lian GD, Qian CC, Chen SJ, Huang KH. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol. 2012;36:583-591. [PMID: 22704816 DOI: 10.1016/j.clinre.2012.04.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
539 De Vincentis A, Pennazza G, Santonico M, Vespasiani-Gentilucci U, Galati G, Gallo P, Zompanti A, Pedone C, Antonelli Incalzi R, Picardi A. Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients. Liver Int. 2017;37:242-250. [PMID: 27496750 DOI: 10.1111/liv.13214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
540 Mariante-Neto G, Brandão AB. Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females? Transplantation 2015;99:2337-40. [PMID: 26177085 DOI: 10.1097/TP.0000000000000747] [Reference Citation Analysis]
541 Wu FL, Shi KQ, Chen YP, Braddock M, Zou H, Zheng MH. Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review. Expert Rev Gastroenterol Hepatol 2014;8:623-32. [PMID: 24762209 DOI: 10.1586/17474124.2014.906899] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
542 de Araujo A, de Barros Lopes A, Trucollo Michalczuk M, Stifft J, Nardelli E, Escobar G, Rossi G, Alvares-da-Silva MR. Is there yet any place for reagent strips in diagnosing spontaneous bacterial peritonitis in cirrhotic patients? An accuracy and cost-effectiveness study in Brazil. J Gastroenterol Hepatol. 2008;23:1895-1900. [PMID: 19120878 DOI: 10.1111/j.1440-1746.2008.05571.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
543 Dumitrescu G, Januszkiewicz A, Ågren A, Magnusson M, Wahlin S, Wernerman J. Thromboelastometry: Relation to the severity of liver cirrhosis in patients considered for liver transplantation. Medicine (Baltimore) 2017;96:e7101. [PMID: 28591054 DOI: 10.1097/MD.0000000000007101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
544 Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am. 2009;93:931-950, ix. [PMID: 19577123 DOI: 10.1016/j.mcna.2009.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
545 Kellett J. Prognostication — The lost skill of medicine. European Journal of Internal Medicine 2008;19:155-64. [DOI: 10.1016/j.ejim.2007.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
546 Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003;52:134-139. [PMID: 12477775 DOI: 10.1136/gut.52.1.134] [Cited by in Crossref: 221] [Cited by in F6Publishing: 198] [Article Influence: 11.6] [Reference Citation Analysis]
547 Tuttle-newhall JE, Collins BH, Desai DM, Kuo PC, Heneghan MA. The current status of living donor liver transplantation. Current Problems in Surgery 2005;42:144-83. [DOI: 10.1067/j.cpsurg.2004.12.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
548 Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, Kim WT, Byun JH. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352-361. [PMID: 18008352 DOI: 10.1002/cncr.23185] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
549 Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications. Clin Transplant 2020;34:e13817. [PMID: 32027405 DOI: 10.1111/ctr.13817] [Reference Citation Analysis]
550 Monescillo A, Mart�nez-lagares F, Ruiz-del-arbol L, Sierra A, Guevara C, Jim�nez E, Marrero JM, Buceta E, S�nchez J, Castellot A, Pe�ate M, Cruz A, Pe�a E. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40:793-801. [DOI: 10.1002/hep.20386] [Cited by in Crossref: 322] [Cited by in F6Publishing: 217] [Article Influence: 17.9] [Reference Citation Analysis]
551 Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793-801. [PMID: 15382120 DOI: 10.1002/hep.1840400408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
552 Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep 2021;11:13834. [PMID: 34226640 DOI: 10.1038/s41598-021-93392-5] [Reference Citation Analysis]
553 Fox AN, Brown RS. Is the Patient a Candidate for Liver Transplantation? Clinics in Liver Disease 2012;16:435-48. [DOI: 10.1016/j.cld.2012.03.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
554 Gao F, Li X, Wan G, Li Y, Zhang Q, Liu Y, Liu H, Li H, Wang X. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. BMC Gastroenterol. 2018;18:179. [PMID: 30509201 DOI: 10.1186/s12876-018-0911-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
555 Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D'Ambrosio D, Gioia S, Ginanni Corradini S, Lucidi C, Mennini G, Rossi M, Merli M, Riggio O. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. Dig Liver Dis 2019;51:1508-12. [PMID: 31601536 DOI: 10.1016/j.dld.2019.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
556 Mohamed M, Katz AW, Tejani MA, Sharma AK, Kashyap R, Noel MS, Qiu H, Hezel AF, Ramaraju GA, Dokus MK, Orloff MS. Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. Adv Radiat Oncol 2016;1:35-42. [PMID: 28799575 DOI: 10.1016/j.adro.2015.12.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
557 Gotardo DRM, Strauss E, Teixeira MD, Machado MCC. Liver transplantation and quality of life: relevance of a specific liver disease questionnaire: Liver transplantation and quality of life. Liver International 2008;28:99-106. [DOI: 10.1111/j.1478-3231.2007.01606.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
558 Campani C, Capone M, Liotta F, Arena U, Adotti V, Di Bonaventura C, Aburas S, Colagrande S, Calistri L, Annunziato F, Marra F. Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma. Dig Liver Dis 2021:S1590-8658(21)00850-1. [PMID: 34876355 DOI: 10.1016/j.dld.2021.11.010] [Reference Citation Analysis]
559 Choi JW, Yoon KT, Park JY, Kim JK, Ahn SH, Paik YH, Lee KS, Han K, Chon CY, Kim DY. Usefulness and Safety of Extracorporeal Liver Support Therapy Using MARS® for Patients with Liver Failure: A Preliminary Report. Korean J Gastroenterol 2009;54:28. [DOI: 10.4166/kjg.2009.54.1.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
560 Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006;12:754-61. [PMID: 16528716 DOI: 10.1002/lt.20686] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
561 Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003;9:473-476. [PMID: 12740789 DOI: 10.1053/jlts.2003.50090] [Cited by in Crossref: 163] [Cited by in F6Publishing: 146] [Article Influence: 8.6] [Reference Citation Analysis]
562 Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. Eur J Clin Invest. 2009;39:65-71. [PMID: 19087131 DOI: 10.1111/j.1365-2362.2008.02063.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
563 Latt NL, Niazi M, Pyrsopoulos NT. Liver transplant allocation policies and outcomes in United States: A comprehensive review. World J Methodol 2022; 12(1): 32-42 [DOI: 10.5662/wjm.v12.i1.32] [Reference Citation Analysis]
564 Shalimar, Jain S, Gamanagatti SR, Kedia S, Thakur B, Nayak B, Kaur H, Gunjan D, Paul SB, Acharya SK. Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma. J Clin Exp Hepatol 2018;8:28-34. [PMID: 29743794 DOI: 10.1016/j.jceh.2017.05.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
565 Bhandari P, Shah Z, Patel K, Patel R. Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease. J Community Hosp Intern Med Perspect 2019;9:403-9. [PMID: 31723384 DOI: 10.1080/20009666.2019.1661148] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
566 Sharma P, Rakela J. Management of pre-liver transplantation patients?Part 1. Liver Transpl 2005;11:124-33. [DOI: 10.1002/lt.20353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
567 Sugawara Y, Makuuchi M, Kaneko J, Akamatsu N, Imamura H, Kokudo N. Living donor liver transplantation for hepatitis B cirrhosis. Liver Transpl 2003;9:1181-4. [PMID: 14586879 DOI: 10.1053/jlts.2003.50237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
568 Marrero J, Martinez FJ, Hyzy R. Advances in Critical Care Hepatology. Am J Respir Crit Care Med 2003;168:1421-6. [DOI: 10.1164/rccm.200303-361up] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
569 Tan H, Schiano TD. Effects of Liver Disease on Drug Metabolism in Humans. Encyclopedia of Drug Metabolism and Interactions. Hoboken: John Wiley & Sons, Inc.; 2011. [DOI: 10.1002/9780470921920.edm125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
570 Hu H, Chen GF, Yuan W, Wang JH, Zhai B. Microwave ablation with chemoembolization for large hepatocellular carcinoma in patients with cirrhosis. Int J Hyperthermia 2018;34:1351-8. [PMID: 29720001 DOI: 10.1080/02656736.2018.1462536] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
571 Teh SH, Sheppard BC, Schwartz J, Orloff SL. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. Am J Surg. 2008;195:697-701. [PMID: 18367132 DOI: 10.1016/j.amjsurg.2007.05.054] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
572 Song CS, Yoon MY, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital]. Korean J Gastroenterol 2011;57:340-5. [PMID: 21694485 DOI: 10.4166/kjg.2011.57.6.340] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
573 Francoz C, Sola E. Assessment of renal function in cirrhosis: Sarcopenia, gender and ethnicity matter. Journal of Hepatology 2019;70:828-30. [DOI: 10.1016/j.jhep.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
574 Brandsæter B. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list. Liver Transplantation 2003;9:961-9. [DOI: 10.1053/jlts.2003.50169] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
575 Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M. Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts. The American Journal of Gastroenterology 2008;103:2738-46. [DOI: 10.1111/j.1572-0241.2008.02102.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 11.1] [Reference Citation Analysis]
576 Neeff HP, Streule GC, Drognitz O, Tittelbach-Helmrich D, Spangenberg HC, Hopt UT, Makowiec F. Early mortality and long-term survival after abdominal surgery in patients with liver cirrhosis. Surgery 2014;155:623-32. [PMID: 24468037 DOI: 10.1016/j.surg.2013.11.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
577 Walker NM, Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Hepatology. 2010;51:1683-1691. [PMID: 20225256 DOI: 10.1002/hep.23537] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
578 Khorsandi SE, Giorgakis E, Vilca-Melendez H, O’Grady J, Heneghan M, Aluvihare V, Suddle A, Agarwal K, Menon K, Prachalias A, Srinivasan P, Rela M, Jassem W, Heaton N. Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant 2017; 7(3): 203-212 [PMID: 28698837 DOI: 10.5500/wjt.v7.i3.203] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
579 Núñez O, García A, Rincón D, Alonso S, Bañares R, Echenagusía A. Derivación portosistémica percutánea intrahepática como tratamiento del hidrotórax hepático refractario. Gastroenterología y Hepatología 2002;25:143-7. [DOI: 10.1016/s0210-5705(02)79007-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
580 Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int 2004;24:465-70. [PMID: 15482344 DOI: 10.1111/j.1478-3231.2004.0949.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
581 Zimmerman MA, Selim M, Kim J, Kozeniecki M, Hong JC. A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients. Transplant Proc 2018;50:2619-21. [PMID: 30348452 DOI: 10.1016/j.transproceed.2018.03.066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
582 Sugiyama C, Akai A, Yamakita N, Ikeda T, Yasuda K. Muscle hematoma: A critically important complication of alcoholic liver cirrhosis. World J Gastroenterol 2009; 15(35): 4457-4460 [PMID: 19764102 DOI: 10.3748/wjg.15.4457] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
583 Linecker M, Kambakamba P, Reiner CS, Linh Nguyen-Kim TD, Stavrou GA, Jenner RM, Oldhafer KJ, Björnsson B, Schlegel A, Györi G, Schneider MA, Lesurtel M, Clavien PA, Petrowsky H. How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasiveness. Surgery 2017;161:453-64. [PMID: 27814957 DOI: 10.1016/j.surg.2016.08.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
584 Pereira R, Bagulho L, Cardoso FS. Acute-on-chronic liver failure syndrome - clinical results from an intensive care unit in a liver transplant center. Rev Bras Ter Intensiva 2020;32:49-57. [PMID: 32401978 DOI: 10.5935/0103-507x.20200009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
585 Frasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005;101:30-7, table of contents. [PMID: 15976201 DOI: 10.1213/01.ANE.0000155288.57914.0D] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
586 Schlögl M, Pak ES, Bansal AD, Schell JO, Ganai S, Kamal AH, Swetz KM, Maguire JM, Perrakis A, Warraich HJ, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Critical Illness and Heart, Kidney, and Liver Diseases. J Palliat Med 2021. [PMID: 34283924 DOI: 10.1089/jpm.2021.0330] [Reference Citation Analysis]
587 Song DS, Kim TY, Kim DJ, Kim HY, Sinn DH, Yoon EL, Kim CW, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Choe WH, Yim HJ, Kim SE, Baik SK, Jang JY, Kim HS, Kim SG, Yang JM, Sohn JH, Choi EH, Cho HC, Jeong SW, Kim MY;  Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group. Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure. J Gastroenterol Hepatol. 2018;33:900-909. [PMID: 28921629 DOI: 10.1111/jgh.13991] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
588 Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003;78:197-210. [PMID: 12583530 DOI: 10.4065/78.2.197] [Cited by in Crossref: 69] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
589 Ahmed A, Keeffe EB. Current indications and contraindications for liver transplantation. Clin Liver Dis. 2007;11:227-247. [PMID: 17606204 DOI: 10.1016/j.cld.2007.04.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
590 Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, Castiglione AG, Valente R, Ravazzoni F, Domenico SD, Valente U. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation*. Transplant Int 2005;18:65-72. [DOI: 10.1111/j.1432-2277.2004.00024.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
591 Yoon CJ, Chung JW, Park JH. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding in patients with viral liver cirrhosis: predictors of early mortality. AJR Am J Roentgenol. 2005;185:885-889. [PMID: 16177405 DOI: 10.2214/AJR.04.0607] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
592 Boike JR, Mazumder NR, Kolli KP, Ge J, German M, Jest N, Morelli G, Spengler E, Said A, Lai JC, Desai AP, Couri T, Paul S, Frenette C, Verna EC, Rahim U, Goel A, Gregory D, Thornburg B, VanWagner LB; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study. Am J Gastroenterol 2021. [PMID: 34158464 DOI: 10.14309/ajg.0000000000001357] [Reference Citation Analysis]
593 Selvaggi G. Patient Selection in Liver Transplant: When Is It the Right Time to List? Mayo Clinic Proceedings 2008;83:140-2. [DOI: 10.4065/83.2.140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
594 Arulraj R, Mangat KS, Tripathi D. Embolization of bleeding stomal varices by direct percutaneous approach. Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S210-S213. [PMID: 20467869 DOI: 10.1007/s00270-010-9886-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
595 da Silveira F, Soares PHR, Marchesan LQ, da Fonseca RSA, Nedel WL. Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better. World J Hepatol 2021; 13(10): 1341-1350 [PMID: 34786170 DOI: 10.4254/wjh.v13.i10.1341] [Reference Citation Analysis]
596 Isbell C, Cohn SM, Inaba K, O'Keeffe T, De Moya M, Demissie S, Ghneim M, Davis ML. Cirrhosis, Operative Trauma, Transfusion, and Mortality: A Multicenter Retrospective Observational Study. Cureus 2018;10:e3087. [PMID: 30324043 DOI: 10.7759/cureus.3087] [Reference Citation Analysis]
597 Goel A, Kim WR. Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era. Clinics in Liver Disease 2018;22:563-78. [DOI: 10.1016/j.cld.2018.03.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
598 Chang Y, Liu QY, Zhang Q, Rong YM, Lu CZ, Li H. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(29): 4288-4301 [PMID: 32848334 DOI: 10.3748/wjg.v26.i29.4288] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
599 McCormack L, Gadano A, Lendoire J, Imventarza O, Andriani O, Gil O, Toselli L, Bisigniano L, de Santibañes E. Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States? HPB (Oxford) 2010;12:456-64. [PMID: 20815854 DOI: 10.1111/j.1477-2574.2010.00199.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
600 Tajiri K, Tokimitsu Y, Ito H, Atarashi Y, Kawai K, Minemura M, Yasumura S, Takahara T, Shimizu Y, Sugiyama T. Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Dig Dis 2018;36:314-21. [PMID: 29852495 DOI: 10.1159/000489258] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
601 Cowgill SM, Thometz D, Clark W, Villadolid D, Carey E, Pinkas D, Zervos E, Rosemurgy A. Conventional Predictors of Survival Poorly Predict and Significantly Underpredict Survival after H-graft Portacaval Shunts. J Gastrointest Surg 2007;11:89-94. [DOI: 10.1007/s11605-006-0041-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
602 Kumar AS, Sibia RS. Predictors of in-hospital mortality among patients presenting with variceal gastrointestinal bleeding. Saudi J Gastroenterol 2015;21:43-6. [PMID: 25672238 DOI: 10.4103/1319-3767.151226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
603 Panzera P, Cicco G, Memeo R, Catalano G, Greco L, Staffieri F, Lupo L, Memeo V. MELD Predictive Value of Alterations of Brain Perfusion During Liver Transplantation. Transplantation Proceedings 2005;37:2622-5. [DOI: 10.1016/j.transproceed.2005.06.094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
604 de Campos Junior ID, Stucchi RS, Udo EY, Boin Ide F. Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients. Hepatol Int. 2015;9:113-119. [PMID: 25788385 DOI: 10.1007/s12072-014-9563-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
605 Niu XK, Das SK, Wu HL, Chen Y. Computed tomography-based score model/nomogram for predicting technical and midterm outcomes in transjugular intrahepatic portosystemic shunt treatment for symptomatic portal cavernoma. World J Clin Cases 2020; 8(5): 887-899 [PMID: 32190625 DOI: 10.12998/wjcc.v8.i5.887] [Reference Citation Analysis]
606 Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013;38:345-354. [PMID: 24107793 DOI: 10.1159/000355540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
607 Krige J, Spence RT, Jonas E, Hoogerboord M, Ellsmere J. A New Recalibrated Four-Category Child-Pugh Score Performs Better than the Original Child-Pugh and MELD Scores in Predicting In-Hospital Mortality in Decompensated Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: a Real-World Cohort Analysis. World J Surg. 2020;44:241-246. [PMID: 31583458 DOI: 10.1007/s00268-019-05211-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
608 Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, Cha S, Kamath P, Kim R, Nagorney DM. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005;9:1207-1215; discussion 1215. [PMID: 16332475 DOI: 10.1016/j.gassur.2005.09.008] [Cited by in Crossref: 170] [Cited by in F6Publishing: 140] [Article Influence: 10.6] [Reference Citation Analysis]
609 Taylor GA, Fagenson AM, Kuo LE, Pitt HA, Lau KN. Predicting Operative Outcomes in Patients with Liver Disease: Albumin-Bilirubin Score vs Model for End-Stage Liver Disease-Sodium Score. J Am Coll Surg 2021;232:470-480.e2. [PMID: 33346079 DOI: 10.1016/j.jamcollsurg.2020.11.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
610 Moreau R. Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol. 2002;17:739-747. [PMID: 12121502 DOI: 10.1046/j.1440-1746.2002.02778.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
611 Elmoghazy W, Ahmed K, Vijay A, Kamel Y, Elaffandi A, El-Ansari W, Kakil R, Khalaf H. Hepatocellular carcinoma in a rapidly growing community: Epidemiology, clinico-pathology and predictors of extrahepatic metastasis. Arab J Gastroenterol 2019;20:38-43. [PMID: 30853257 DOI: 10.1016/j.ajg.2019.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
612 Smith AD, Veniero JC. Gd-EOB-DTPA as a functional MR cholangiography contrast agent: imaging gallbladder filling in patients with and without hepatobiliary dysfunction. J Comput Assist Tomogr. 2011;35:439-445. [PMID: 21765298 DOI: 10.1097/RCT.0b013e31821f4e29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
613 Ge J, Lai JC, Boike JR, German M, Jest N, Morelli G, Spengler E, Said A, Lee A, Hristov A, Desai AP, Junna S, Pokhrel B, Couri T, Paul S, Frenette C, Christian-Miller N, Laurito M, Verna EC, Rahim U, Goel A, Das A, Pine S, Gregory D, VanWagner LB, Kolli KP; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. Liver Transpl 2021;27:329-40. [PMID: 33217178 DOI: 10.1002/lt.25949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
614 Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol 2014; 20(45): 16996-17010 [PMID: 25493012 DOI: 10.3748/wjg.v20.i45.16996] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
615 Oton-nieto E, Barcena-marugan R, Carrera-alonso E, Blesa-radigales C, Garcia-gonzalez M, Nuño J, Plaza-palacios G, Garcia-plaza A. Variability of MELD Score During the Year Before Liver Transplantation. Transplantation Proceedings 2005;37:3887-8. [DOI: 10.1016/j.transproceed.2005.09.164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
616 Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52:605-613. [PMID: 20185192 DOI: 10.1016/j.jhep.2009.11.025] [Cited by in Crossref: 155] [Cited by in F6Publishing: 125] [Article Influence: 12.9] [Reference Citation Analysis]
617 Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584-590. [PMID: 25846824 DOI: 10.1002/hep.27830] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 14.9] [Reference Citation Analysis]
618 Woo HY, Choi JY, Yoon SK, Suh DJ, Paik SW, Han KH, Um SH, Kim BI, Lee HJ, Cho M, Lee CK, Kim DJ, Hwang JS. Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus. Clin Mol Hepatol 2014;20:168-76. [PMID: 25032183 DOI: 10.3350/cmh.2014.20.2.168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
619 Asrani SK, Kamath PS. Prediction of early mortality after variceal bleeding: score one more for MELD. Gastroenterology 2014;146:337-9. [PMID: 24361433 DOI: 10.1053/j.gastro.2013.12.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
620 Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol. 2014;49:324-331. [PMID: 23478939 DOI: 10.1007/s00535-013-0782-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
621 Alqahtani SA, Larson AM. Adult liver transplantation in the USA: . Current Opinion in Gastroenterology 2011;27:240-7. [DOI: 10.1097/mog.0b013e3283457d5d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
622 Pascual S, Zapater P, Such J, Garcia-herola A, Sempere L, Irurzun J, Palazon JM, Carnicer F, Perez-mateo M. Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver Int 2006;26:673-9. [DOI: 10.1111/j.1478-3231.2006.01282.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
623 Saraswat V, Singh SP, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Puri P, Narayanswami K, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Varghese T, Acharya SK; Shalimar. Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience: ACLF-Indian experience. Journal of Gastroenterology and Hepatology 2016;31:1742-9. [DOI: 10.1111/jgh.13340] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
624 Mansour-ghanaei F, Mehrdad M, Mortazavi S, Joukar F, Khak M, Atrkar-roushan Z. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Annals of Hepatology 2012;11:667-71. [DOI: 10.1016/s1665-2681(19)31440-1] [Cited by in Crossref: 19] [Article Influence: 1.9] [Reference Citation Analysis]
625 Kim JH, Kim JH, Choi JH, Kim CH, Jung YK, Yim HJ, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol 2009;44:346-57. [PMID: 18991165 DOI: 10.1080/00365520802530838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
626 Olson JC, Saeian K. Gastrointestinal Issues in Liver Disease. Crit Care Clin 2016;32:371-84. [PMID: 27339677 DOI: 10.1016/j.ccc.2016.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
627 Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4:266-276. [PMID: 17476209 DOI: 10.1038/ncpgasthep0794] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
628 Ximenes RO, Farias AQ, Scalabrini Neto A, Diniz MA, Kubota GT, Ivo MM, Colacique CG, D’Albuquerque LA, Daglius Dias R. Patients with cirrhosis in the ED: early predictors of infection and mortality. Am J Emerg Med. 2016;34:25-29. [PMID: 26423777 DOI: 10.1016/j.ajem.2015.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
629 Zhao J, Zhang M, Quan Z, Deng L, Li Y, He B. Systematic Influence of Circulating Bilirubin Levels on Osteoporosis. Front Endocrinol (Lausanne) 2021;12:719920. [PMID: 34539572 DOI: 10.3389/fendo.2021.719920] [Reference Citation Analysis]
630 Wang Z, Chen T, Ge M, Chen C, Lu L, Zhang L, Wang D. The risk factors and outcomes of preoperative hepatic dysfunction in patients who receive surgical repair for acute type A aortic dissection. J Thorac Dis 2021;13:5638-48. [PMID: 34795914 DOI: 10.21037/jtd-21-1051] [Reference Citation Analysis]
631 Kuiper EM, Hansen BE, Metselaar HJ, de Man RA, Haagsma EB, van Hoek B, van Buuren HR. Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. BMC Gastroenterol. 2010;10:144. [PMID: 21172005 DOI: 10.1186/1471-230X-10-144] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
632 Lee M, Tae H, Jun D, Ryu S, Choi Y, Kwak M, Kang J. 201Tl Heart-Liver Radioactivity Uptake Ratio and Prediction of Decompensation in Patients With Cirrhosis. Clinical Nuclear Medicine 2013;38:169-74. [DOI: 10.1097/rlu.0b013e31827087e3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
633 Gonsalkorala ES, Cannon MD, Lim TY, Penna L, Willliamson C, Heneghan MA. Non-Invasive Markers (ALBI and APRI) Predict Pregnancy Outcomes in Women With Chronic Liver Disease. Am J Gastroenterol 2019;114:267-75. [DOI: 10.1038/s41395-018-0181-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
634 Andrade RJ, Robles‐díaz M. Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice. Liver Int 2019;40:6-17. [DOI: 10.1111/liv.14271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
635 Garcia N, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38:52-58. [PMID: 14679328 DOI: 10.1097/00004836-200401000-00012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
636 Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray NG, Goldstein RM, Klintmalm GB. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 2003;9:117-123. [PMID: 12548503 DOI: 10.1053/jlts.2003.50027] [Cited by in Crossref: 160] [Cited by in F6Publishing: 142] [Article Influence: 8.4] [Reference Citation Analysis]
637 Leventhal TM, Florek E, Chinnakotla S. Changes in liver allocation in United States. Current Opinion in Organ Transplantation 2020;25:52-8. [DOI: 10.1097/mot.0000000000000726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
638 Rajvanshi P, McDonald GB. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease. Liver Transpl 2001;7:154-7. [PMID: 11172402 DOI: 10.1053/jlts.2001.0070154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
639 Cabibbo G, Petta S, Barbara M, Attardo S, Bucci L, Farinati F, Giannini EG, Negrini G, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Virdone R, Marra F, Mega A, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Colecchia A, Persico M, Craxì A, Trevisani F, Cammà C; Italian Liver Cancer (ITA.LI.CA) group. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. J Hepatol 2017;67:65-71. [PMID: 28192185 DOI: 10.1016/j.jhep.2017.01.033] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
640 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
641 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 12.6] [Reference Citation Analysis]
642 Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008;10:30-5. [DOI: 10.1007/s11894-008-0006-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
643 Lee H, Yang SM, Chung J, Oh H, Yi NJ, Suh K, Oh S, Ryu HG. Effect of Perioperative Low-Dose Dexmedetomidine on Postoperative Delirium After Living-Donor Liver Transplantation: A Randomized Controlled Trial. Transplantation Proceedings 2020;52:239-45. [DOI: 10.1016/j.transproceed.2019.11.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
644 Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48:229-36. [PMID: 18093686 DOI: 10.1016/j.jhep.2007.10.008] [Cited by in Crossref: 203] [Cited by in F6Publishing: 151] [Article Influence: 13.5] [Reference Citation Analysis]
645 Kim WR. Models predicting the natural history of cirrhosis and need for liver transplantation: . Current Opinion in Organ Transplantation 2001;6:107-13. [DOI: 10.1097/00075200-200106000-00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
646 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
647 Hackl C, Schlitt HJ, Renner P, Lang SA. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol 2016; 22(9): 2725-2735 [PMID: 26973411 DOI: 10.3748/wjg.v22.i9.2725] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
648 Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, Nicolini A. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869-875. [PMID: 17135305 DOI: 10.1136/gut.2006.102467] [Cited by in Crossref: 144] [Cited by in F6Publishing: 114] [Article Influence: 9.0] [Reference Citation Analysis]
649 Yoo HY, Edwin D, Thuluvath PJ. Relationship of The Model for End-Stage Liver Disease (Meld) Scale To Hepatic Encephalopathy, As Defined by Electroencephalography and Neuropsychometric Testing, and Ascites. American Journal of Gastroenterology 2003;98:1395-9. [DOI: 10.1111/j.1572-0241.2003.07466.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
650 Ascha M, Hanouneh M, S. Ascha M, Zein NN, Sands M, Lopez R, Hanouneh IA. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15. Dig Dis Sci 2017;62:534-42. [DOI: 10.1007/s10620-016-4185-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
651 McCudden C, Akbari A, White CA, Biyani M, Hiremath S, Brown PA, Tangri N, Brimble S, Knoll G, Blake PG, Sood MM. Individual patient variability with the application of the kidney failure risk equation in advanced chronic kidney disease. PLoS One 2018;13:e0198456. [PMID: 29894480 DOI: 10.1371/journal.pone.0198456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
652 Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. The American Journal of Surgery 2012;203:589-93. [DOI: 10.1016/j.amjsurg.2012.01.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
653 Koo JK, Kim JH, Choi YJ, Lee CI, Yang JH, Yoon HY, Choi HJ, Ko SY, Choe WH, Kwon SY, Lee CH. Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis: Value of Refit Model for End-stage Liver Disease. J Gastroenterol Hepatol 2013;28:1209-16. [DOI: 10.1111/jgh.12156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
654 Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, Büchler MW, Weitz J. The Predictive Value of Postoperative Clinical Risk Scores for Outcome After Hepatic Resection: A Validation Analysis in 807 Patients. Ann Surg Oncol 2011;18:3640-9. [DOI: 10.1245/s10434-011-1829-6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 8.2] [Reference Citation Analysis]
655 Zakareya T, Abbasy M, Abdel-razek W, Elsiesy H, Abal Khail F, Al Sebayel M, Waked I. Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality: . European Journal of Gastroenterology & Hepatology 2017;29:1424-7. [DOI: 10.1097/meg.0000000000000957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 Sarno G, Montalti R, Giglio MC, Rompianesi G, Tomassini F, Scarpellini E, De Simone G, De Palma GD, Troisi RI. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment. Surg Oncol. 2021;36:42-50. [PMID: 33307490 DOI: 10.1016/j.suronc.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
657 Pillai A, Couri T, Charlton M. Liver Allocation Policies in the USA: Past, Present, and the Future. Dig Dis Sci 2019;64:985-92. [DOI: 10.1007/s10620-019-05549-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
658 Rivkina A, Rybalov S. Chronic hepatitis B: current and future treatment options. Pharmacotherapy. 2002;22:721-737. [PMID: 12066963 DOI: 10.1592/phco.22.9.721.34058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
659 Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L, La Barba G, Foxton MR, Rela M, O'Grady J, Pinna AD. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007;56:253-8. [PMID: 16809421 DOI: 10.1136/gut.2005.084434] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
660 Na SH, Kim EJ, Nam EY, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim HB, Oh MD, Kim NJ. Comparison of clinical characteristics and outcomes of spontaneous bacterial peritonitis and culture negative neutrocytic ascites. Scand J Gastroenterol. 2017;52:199-203. [PMID: 27797274 DOI: 10.1080/00365521.2016.1245776] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
661 Ross S, Thometz D, Serafini F, Bloomston M, Morton C, Zervos E, Rosemurgy A. Renal haemodynamics and function following partial portal decompression. HPB (Oxford) 2009;11:229-34. [PMID: 19590652 DOI: 10.1111/j.1477-2574.2009.00040.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
662 Scott RA, Austin AS, Kolhe NV, McIntyre CW, Selby NM. Acute kidney injury is independently associated with death in patients with cirrhosis. Frontline Gastroenterol 2013;4:191-7. [PMID: 24660054 DOI: 10.1136/flgastro-2012-100291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
663 Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: Meaning of the model for end-stage liver disease. J Am Coll Surg. 2006;203:670-676. [PMID: 17084328 DOI: 10.1016/j.jamcollsurg.2006.06.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
664 Lan P, Wang SJ, Shi QC, Fu Y, Xu QY, Chen T, Yu YX, Pan KH, Lin L, Zhou JC, Yu YS. Comparison of the predictive value of scoring systems on the prognosis of cirrhotic patients with suspected infection. Medicine (Baltimore). 2018;97:e11421. [PMID: 29995791 DOI: 10.1097/md.0000000000011421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
665 King A, Masterton G, Gunson B, Olliff S, Redhead D, Mangat K, Oniscu G, Hayes P, Tripathi D. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation: Tips in Liver Transplant Recipients. Liver Transpl 2011;17:771-8. [DOI: 10.1002/lt.22281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
666 Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sørensen HT. Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology. 2008;48:214-220. [PMID: 18537190 DOI: 10.1002/hep.22341] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
667 Harada N, Shirabe K, Ijichi H, Matono R, Uchiyama H, Yoshizumi T, Taketomi A, Soejima Y, Maehara Y. Acoustic radiation force impulse imaging predicts postoperative ascites resulting from curative hepatic resection for hepatocellular carcinoma. Surgery 2012;151:837-43. [PMID: 22386275 DOI: 10.1016/j.surg.2011.12.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
668 Umbro I, Tinti F, Scalera I, Evison F, Gunson B, Sharif A, Ferguson J, Muiesan P, Mitterhofer AP. Acute kidney injury and post-reperfusion syndrome in liver transplantation. World J Gastroenterol 2016; 22(42): 9314-9323 [PMID: 27895419 DOI: 10.3748/wjg.v22.i42.9314] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
669 Mai R, Zeng J, Lu H, Liang R, Lin Y, Piao X, Gao X, Wu G, Wu F, Ma L, Xiang B, Li L, Ye J. Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma. J Gastrointest Surg 2021;25:688-97. [DOI: 10.1007/s11605-020-04575-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
670 Trieu JA, Bilal M, Hmoud B. Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database. Ann Gastroenterol 2018;31:84-9. [PMID: 29333071 DOI: 10.20524/aog.2017.0217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
671 Zhang YB, Lu Y, Wu WD, Zhang CW, Shen GL, Hong dF. Indocyanine green retention is a potential prognostic indicator after splenectomy and pericardial devascularization for cirrhotic patients. Hepatobiliary Pancreat Dis Int. 2016;15:386-390. [PMID: 27498578 DOI: 10.1016/s1499-3872(16)60114-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
672 Kasahara M, Egawa H, Takada Y, Oike F, Sakamoto S, Kiuchi T, Yazumi S, Shibata T, Tanaka K. Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients. Ann Surg 2006;243:559-66. [PMID: 16552210 DOI: 10.1097/01.sla.0000206419.65678.2e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
673 Boone MD, Celi LA, Ho BG, Pencina M, Curry MP, Lior Y, Talmor D, Novack V. Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients. J Crit Care. 2014;29:881.e7-881.13. [PMID: 24974049 DOI: 10.1016/j.jcrc.2014.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
674 Garcia-Tsao G. The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back. Dig Dis Sci 2016;61:3102-4. [PMID: 27696097 DOI: 10.1007/s10620-016-4319-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
675 Rongey C, Kaplowitz N. Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol 2006; 12(43): 6909-6921 [PMID: 17109510 DOI: 10.3748/wjg.v12.i43.6909] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
676 Tautenhahn HM, Rauchfuß F, Ali Deeb A, Bauschke A, Settmacher U. [Living related liver transplantation]. Chirurg 2020;91:926-33. [PMID: 32909072 DOI: 10.1007/s00104-020-01268-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
677 Schlansky B, Lee B, Hartwell L, Urquhart J, Willis B, Zaman A. Guideline adherence and outcomes in esophageal variceal hemorrhage: comparison of tertiary care and non-tertiary care settings. J Clin Gastroenterol. 2012;46:235-242. [PMID: 21778893 DOI: 10.1097/mcg.0b013e318227422d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
678 Xia VW, Du B, Braunfeld M, Neelakanta G, Hu KQ, Nourmand H, Levin P, Enriquez R, Hiatt JR, Ghobrial RM. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl. 2006;12:614-620. [PMID: 16555319 DOI: 10.1002/lt.20679] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article In